Hydroalkynylation of Oxocarbenium Intermediates via Au(I) Catalysis by Smith, Courtney Smith
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
2-28-2017
Hydroalkynylation of Oxocarbenium
Intermediates via Au(I) Catalysis
Courtney Smith Smith
University of South Florida, casmit16@mail.usf.edu
Follow this and additional works at: http://scholarcommons.usf.edu/etd
Part of the Chemistry Commons
This Thesis is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate
Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact scholarcommons@usf.edu.
Scholar Commons Citation
Smith, Courtney Smith, "Hydroalkynylation of Oxocarbenium Intermediates via Au(I) Catalysis" (2017). Graduate Theses and
Dissertations.
http://scholarcommons.usf.edu/etd/6762
 
 
 
 
 
 
 
Hydroalkynylation of Oxocarbenium Intermediates via Au(I) Catalysis 
 
 
 
by 
 
 
 
Courtney A. Smith 
 
 
 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
Master of Science 
Department of Chemistry 
College of Arts and Sciences 
University of South Florida 
 
 
 
Major Professor: X. Michael Shi, Ph.D. 
Shengqian Ma, Ph.D. 
Jianfeng Cai, Ph.D. 
 
 
Date of Approval: 
March 20, 2017 
 
 
 
Keywords: gold, enol, catalysis, alkynylation, acetylide, cascade 
 
Copyright © 2017, Courtney A. Smith 
2 
 
 
 
 
 
 
DEDICATION 
 
I dedicate this dissertation to my father and mother, who have provided an insurmountable 
amount of support during this process. 
3 
 
 
 
 
ACKNOWLEDGEMENTS 
I begin by thanking my advisor Dr. Michael Shi who has spent tremendous effort and time 
towards my growth as a chemist. I also want to thank all of the colleagues in Dr. Shi’s lab that I 
have worked with over the past year. In particular, I thank Dr. Quiqin He for providing critical 
feedback and guidance pertaining to the discussed research.
i 
 
 
 
 
 
 
TABLE OF CONTENTS 
 
List of Tables  iii 
 
List of Figures  iv 
 
Abstract  vi 
 
Chapter 1. Recent Developments in Transition-Metal Catalyzed Alkynylation  
 1.1 Introduction 1 
 1.2 Hydroalkynylation of Oxocarbeniums 2 
  1.2.1 Copper-Based Catalysts 3 
  1.2.2 Gold-Based Catalysts 7  
 1.3 Summary 10 
 1.4 References 11 
 
Chapter 2. Gold-Catalyzed Hydroalkynylation of Vinyl Ethers  
 2.1 Introduction  15 
 2.2 Results and Discussion 17  
  2.2.1 Monitoring Catalyst Decomposition 17  
  2.2.2 Screening of Catalytic Conditions 18  
  2.2.3 Substrate Scope of Hydroalkynylation 20  
  2.2.4 Ferrier-Alkynylation Reaction of Glycals 22 
  2.2.5 Mechanistic Investigations 24 
 2.3 Experimental Section 25  
  2.3.1 General Procedure for Synthesizing Compounds 54 28 
  2.3.2 General Procedure for Synthesizing Compounds 58 34 
 2.4 Conclusion 40 
 2.5 References 40 
 
Chapter 3. Alkynol Cycloisomerization-Alkynylation Tandem Reaction  
 3.1 Introduction 44 
 3.2 Results and Discussion 46 
  3.2.1 Screening of Catalytic Conditions 46 
  3.2.2 Substrate Scope 47 
  3.2.3 Ring-Expansion Cascade 49 
  3.2.4 Mechanistic Investigations 51 
 3.3 Experimental Section 53 
  3.3.1 General Coupling Procedure for Synthesizing Compounds  
   47a-47j, 47l 55  
  3.3.2 General Procedure for Synthesizing Compounds 47p, 47q 56  
ii 
 
  3.3.3 General EDC Coupling Procedure 56 
  3.3.4 General Procedure for Synthesizing Compounds 61 58 
3.3.5 General Procedure for Synthesizing Dihydrooxepine  
   Diels Alder Adducts 73 
  3.3.6 1H-NMR Monitoring of Ring Expansion 78 
  3.3.7 X-Ray Crystallographic Data for 61m, 64b, and 64g 79 
 3.4 Conclusion 84 
 3.5 References 84 
 
Appendix A. Spectral Data for Chapter 2 87 
 
Appendix B. Spectral Data for Chapter 3 119  
 
  
iii 
 
 
 
 
 
 
LIST OF TABLES 
 
Table 2.1. Screening of conditions for TA-Au catalyzed hydroalkynylation. 19  
 
Table 2.2. Scope of vinyl ether hydroalkynylation. 21  
 
Table 2.3. Scope of glycal hydroalkynylation-Ferrier elimination. 23 
 
Table 2.4. Comprehensive screening table of catalytic hydroalkynylation. 26 
 
Table 3.1. Screening of catalytic conditions for formation of 60 and 62. 46 
 
Table 3.2. Acetylene substrate scope of tandem cycloisomerization-hydroalkynylation. 48 
 
Table 3.3. Alkynol substrate scope of tandem cycloisomerization-hydroalkynylation. 49 
 
Table 3.4. Substrate scope of ring-opening cascade. 50 
 
Table 3.5. Comprehensive screening table of tandem reaction. 53 
 
Table 3.6. Crystal data and structure refinement for 61m. 81 
 
Table 3.7. Crystal data and structure refinement for 64b. 82 
 
Table 3.8. Crystal data and structure refinement for 64g. 83 
  
iv 
 
 
 
 
 
 
LIST OF FIGURES 
 
Figure 1.1.  Compounds synthesized by oxocarbenium hydroalkynylation. 2  
 
Figure 1.2.  Proposed copper-catalyzed pathway for formation of 3. 3  
 
Figure 1.3.  Enantioselective copper acetylide addition to aldehydes. 3  
 
Figure 1.4.  Synthesis of trifluoromethylcarbinols. 4  
 
Figure 1.5.  Enantiomerically-enriched C3-alkynylated istatins. 5  
 
Figure 1.6.  Enantioselective alkynylation of isochroman acetals. 6 
 
Figure 1.7.  Enantioselective alkynylation of benzopyranyl and α-substituted acetals. 6  
 
Figure 1.8.  Synthesis of 1-alkynyl-1H-isochromenes. 7  
 
Figure 1.9.  Tandem Prins-type cyclization-hydroalkynylation sequence. 8  
 
Figure 1.10.  Auto-tandem catalysis for the synthesis of pyrroles. 8  
 
Figure 1.11.  Hydroalkynylation of N,O-acetals. 9  
 
Figure 1.12.  Acyl silane alkynylation and sp2-C-H alkylation. 10  
 
Figure 2.1.  Compounds synthesized using gold-catalyzed enyne cycloisomerization. 15  
 
Figure 2.2.  Mechanism of gold-catalyzed enyne cycloisomerization. 16 
 
Figure 2.3.  Proposed intermolecular reaction of vinyl ethers and terminal alkynes. 16 
 
Figure 2.4.  Reported cycloisomerization of homo-propargyl alcohols and alkynes. 17  
 
Figure 2.5.  Initial investigation of catalyst stability. 18  
 
Figure 2.6.  Application of copper methodology to simple vinyl ethers. 22  
 
Figure 2.7.  Mechanistic investigation of vinyl ether hydroalkynylation. 25  
 
Figure 2.8.  Procedure for synthesis of tri-arylphosphite gold-acetylide C. 27 
v 
 
 
Figure 3.1.  Selectivity issues arising from Au’s π-acidity. 44 
 
Figure 3.2.  Proposed goals of homopropargyl alcohol gold-catalytic study. 45  
 
Figure 3.3.  X-ray crystal structure of 64b 50  
 
Figure 3.4.  Reaction kinetic profile of ring-opening cascade. 51 
 
Figure 3.5.  Mechanistic investigation of homo-propargyl alcohol reaction. 52 
 
Figure 3.6.  1H-NMR monitoring of ring expansion. 79  
 
Figure 3.7.  Perspective view of molecular structure C22H20FeO with atom labeling. 81 
 
Figure 3.8.  Perspective view of molecular structure C24H16N4O with atom labeling. 82 
 
Figure 3.9.  Perspective view of molecular structure C25H15F3N4O with atom labeling. 83 
 
 
 
 
  
vi 
 
 
 
 
ABSTRACT 
Au(I) catalysis has recently emerged as a powerful tool for the realization of a broad 
range of organic transformations. Despite this rapid development, attaining selectivity and 
maintaining catalyst stability remain significant challenges. Rational ligand design, such as the 
employment of NHC or TA ligands, has been used to confront these issues. This thesis focuses 
on the use of Au(I) catalysts bearing these ligands for the selective hydroalkynylation of enol 
ethers. By employing a TA-Au stabilized catalyst, [(OAr)3PAu(TA-H)]OTf, the intermolecular 
hydroalkynylation of enol ethers, a substrate that is well-known to promote decomposition of the 
gold cation, was efficiently achieved. As an expansion of this reaction, the NHC-Au catalyst, 
IPrAuNTf2, was utilized in a multicomponent system to promote the tandem hydroalkynylation 
of enol ethers formed in-situ via the cycloisomerization of alkynols. Further exploration of this 
tandem reaction revealed that IPrAuNTf2 catalyzes a cascade ring-expansion of the alkynylated 
heterocycles to form oxepines. The mechanistic and synthetic insight obtained from these 
developed reactions has the potential to be applied towards future studies in gold catalysis.  
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CHAPTER 1 
RECENT DEVELOPMENTS IN TRANSITION-METAL CATALYZED 
ALKYNYLATION 
 
1.1 Introduction 
Nucleophilic addition of transition-metal acetylides to activated cationic intermediates 
has provided access to a variety of structures including naturally-occurring compounds bearing 
complex connectivity. Due to the interaction of the Lewis acidic metal center with the π-system 
of the terminal alkyne, the acidity of the acetylenic proton increases. Deprotonation of this 
proton produces the highly nucleophilic acetylide anion, which may interact with a Lewis acidic 
metal to form a metal acetylide intermediate. Utilizing transition metals for the catalytic 
formation of nucleophilic acetylides is an atom-economic and mild alternative to the traditional 
methods which employ strong bases such as alkoxides1 or hydroxides.2 A variety of transition 
metals such as copper and gold frequently exhibit this reactivity and have been utilized for 
reactions involving activated cationic intermediates.3 Other catalysts based on transition metals 
such as silver4, iridium5, zinc6, and lanthanum7 have also been reported. This chapter serves to 
provide a general overview of the current developments in copper and gold-catalyzed 
alkynylation processes involving oxocarbenium intermediates. For the purpose of this thesis, the 
corresponding gold-8 and copper-9 catalyzed reactions in which iminium intermediates are 
involved will not be discussed.  
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Oxocarbenium intermediates may be formed via protonation of a vinyl ether substrate or 
carbonyl, and are inherent to a variety of synthetic processes such as the Prins cyclization.10 The 
lowered least-occupied molecular orbital of the oxocarbenium, owing to oxygen’s high 
electronegativity, renders the oxocarbenium susceptible to nucleophilic attack. This chapter will 
focus primarily on the interaction of these activated intermediates with metal acetylides derived 
from gold or copper catalysts. It should be noted that for this introduction, metal acetylide 
addition to carbonyl substrates will be included in the discussion of oxocarbenium reactions.  
 
1.2 Hydroalkynylation of Oxocarbeniums 
Alkynylation of carbonyls employing catalytic metal acetylides is attractive due to the 
broad synthetic utility of propargylic alcohols. These substrates can be further elaborated for the 
synthesis of heteroaromatic compounds via cycloaddition reactions, allylic alcohols via 
hydrogenation, substituted alkenes via hydrofunctionalization, etc. Moreover, acetals in the 
presence of acid have been used to generate activated oxocarbeniums for subsequent 
alkynylation. 
 
Figure 1.1. Compounds synthesized by oxocarbenium hydroalkynylation. 
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  Transition metal catalysts derived from copper and gold are well-suited towards the 
synthesis of alkynylated oxocarbeniums and have been successfully employed for the synthesis 
of complex naturally-occurring compounds (Figure 1.1).11  
 
1.2.1 Copper-Based Catalysts 
The first example of copper acetylide addition to carbonyls was reported in 1966 with the 
use of copper sulfate and a secondary amine.12 At the onset, the authors purport a pathway 
involving an initial addition of copper acetylide to 1b (Figure 1.2). However, there was 
substantive room for improvement, as the substrate scope was limited and stoichiometric copper 
was required. 
 
 
         Figure 1.2. Proposed copper-catalyzed pathway for formation of 3. 
 
Subsequent reports extended this chemistry towards the enantioselective alkynylation of 
aromatic-substituted aldehydes facilitated by the chiral ferrocenyl ligand L1 (Figure 1.3).13 
Although this report is the first instance of enantioselective copper acetylide addition to 
aldehydes, it should be noted that the ee was moderate (up to 56%).  
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     Figure 1.3. Enantioselective copper acetylide addition to aldehydes. 
 
Next, electron-deficient trifluoromethyl ketones were directly alkynylated in the presence 
of copper alkoxide catalysts and xantphos or phenanthroline.14 A ligand-free system comprised 
of potassium carbonate was also utilized for the synthesis of trifluoromethyl carbinols (Wang, 
2015).15  Michalak and coworkers demonstrated further in 2016 that a N-heterocyclic carbene 
(NHC)-copper complex C1 resulted in milder reaction conditions in aqueous media, enabling a 
broader substrate scope (Figure 1.4).16 This methodology was also suited for the transformation 
of ketones and istatins, albeit higher temperatures were required.  
 
 
      Figure 1.4. Synthesis of trifluoromethylcarbinols. 
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Undoubtedly, the mono-alkynylation of istatins is of interest due to the presence of C-3 
substituted 3-hydroxyindole moieties in naturally-occurring compounds.17 Feng and coworkers 
demonstrated that a copper-catalyst generated in-situ bound to the chiral guanidine ligand L2 is 
amenable to the synthesis of enantiomerically-enriched alkynylated istatin derivatives (Figure 
1.5).18 Direct synthesis of the biologically-active product 11a was efficiently achieved using this 
methodology. 
 
 
Figure 1.5. Enantiomerically-enriched C3-alkynylated istatins. 
 
Lastly, pioneering work conducted by Watson and coworkers utilize isochroman acetals 
for the formation of oxocarbeniums and subsequent enantioselective alkynylation. Acid-
catalyzed activation of isochroman acetals was used to generated these activated intermediates in 
concert with copper acetylides associated with bisoxazoline L3 (Figure 1.6).19  
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        Figure 1.6. Enantioselective alkynylation of isochroman acetals. 
 
The in-situ formation of isochroman oxocarbeniums using stoichiometric acid and 
subsequent enantioselective alkynylation with bisoxazoline-copper complexes proved to be a 
robust strategy for accessing other isochroman derivatives. Extension of this methodology to the 
synthesis of enantiomerically-enriched 18 and 22 was accomplished via the use of ligands L3 
and L4, respectively (Figure 1.6, Figure. 1.7).20-21  
 
 
Figure 1.7. Enantioselective alkynylation of benzopyranyl and α-substituted acetals. 
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1.2.2 Gold-Based Catalysts 
Although less developed than that of copper catalytic systems, alkynylation reactions 
employing gold acetylides have shown potential synthetic utility. The first gold acetylide 
addition to oxocarbeniums was developed by Li and coworkers in 2006. In the presence of 
catalytic gold and tertiary amine base, benzaldehyde derivatives undergo a 5-endo-dig carbonyl 
addition to furnish an oxocarbenium intermediate that is putatively alkynylated by an in-situ 
generated gold acetylide (Figure 1.8).22 Further investigation revealed that the reaction does not 
proceed in the absence of an ortho-alkynyl group, thus revealing the necessity of the 
oxocarbenium.  
 
       Figure 1.8. Synthesis of 1-alkynyl-1H-isochromenes. 
 
Next, Echavarren and coworkers successfully intercepted oxonium ions formed via Prins-
type cyclization of γ, δ unsaturated ketones with gold acetylides derived from L5 (Figure 1.9).23 
Mechanistic investigations confirmed the role of gold acetylides in the formation of the 2-
(arylethynyl)tetrahydrofurans. However, this methodology is limited to para- and meta- 
halogenated phenylacetylenes. 
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      Figure 1.9. Tandem Prins-type cyclization-hydroalkynylation sequence. 
 
Alternatively, the generation of oxocarbeniums was achieved via the activation of acetals. 
Tokuyama and coworkers engineered a substrate consisting of a dimethyl acetal moiety with a 
pendant nucleophilic amide (Figure 1.10).24 Within this “auto-tandem catalysis,” the 
oxocarbenium ion is formed from the dimethyl acetal via an acid-catalyzed process. The 
activated intermediate undergoes intermolecular gold acetylide addition and subsequent gold-
catalyzed 5-endo-dig amination. Finally, protodeauration and aromatization by elimination of 
methanol forms the final functionalized pyrrole products. When tri-substituted N-methyl amides 
are used, the alkynylation product is obtained due to the intermediate’s inability to undergo 
intramolecular amination. 
 
 
          Figure 1.10. Auto-tandem catalysis for the synthesis of pyrroles. 
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 Similarly, Dalla and coworkers utilized N,O-acetals and trimethylsilyltriflate (TMSOTf) 
to generate oxocarbenium ions, which undergo a tandem gold-catalyzed alkynylation with silyl-
substituted alkynes (Figure 1.11).25 Subjecting 30a to equimolar TMSOTf and gold acetylide 
successfully produced the desired alkynylation product, constituting evidence for the 
intermediacy of the gold acetylide. The methodology was also suitable for the transformation of 
the corresponding O-acetals.   
 
 
         Figure 1.11. Hydroalkynylation of N,O-acetals. 
 
Furthermore, Ballesteros and coworkers showed that a synergistic gold-catalyzed 
activation of acyl silanes and subsequent formation of gold acetylides from silyl alkynes was 
suitable for the synthesis of indanones (Scheme 1.1).26 Using the electron-deficient ligand L6, 
acyl silanes undergo a tandem alkynylation and intramolecular C-H alkylation to furnish the 
desired bicyclic compounds. Sigma-activation of the silyl alkyne by gold liberates an oxophilic 
silane that associates with the acyl silane 33, activating it towards nucleophilic attack by gold 
acetylide 35. After attack, silyl migration and resonance forms a carbenoid intermediate 38 that 
undergoes intramolecular arylation and methanolysis to form the final product 40 (Figure 1.12).  
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        Figure 1.12. Acyl silane alkynylation and sp2-C-H alkylation. 
 
1.3 Summary 
Oxocarbenium intermediates may be generated by a variety of methods, and their 
inherent electronic properties facilitate the nucleophilic attack of metal acetylides to the 
electrophilic carbon center. Methods in which these hydroalkynylation products undergo 
additional modification have proved useful for the synthesis of heterocycles. 
 
 
11 
 
1.4 References 
1.  (a) Babler, J. H.; Liptak, V. P.; Phan, N. J. Org. Chem. 1996, 61, 416; (b) Chen, S.; Yuan, 
F.; Zhao, H.; Li, B. Res. Chem. Intermed. 2013, 39, 2391; (c) Zhang, J.; Li, P.; Wang, L. Org. 
Biomol. Chem. 2014, 12, 2969; (d) Miyamoto, H.; Yasaka, S.; Tanaka, K. BCSJ 2001, 74, 185. 
2. (a) Schmidt, E. Y.; Cherimichkina, N. A.; Bidusenko, I. A.; Protzuk, N. I.; Trofimov, B. 
A. Eur. J. Org. Chem. 2014, 2014, 4663; (b) Ishikawa, T.; Mizuta, T.; Hagiwara, K.; Aikawa, T.; 
Kudo, T.; Saito, S. J. Org. Chem. 2003, 68, 3702; (c) Tzalis, D.; Knochel, P. Angew. Chem. Int. 
Ed. 1999, 38, 1463; (d) Liu, J.; Lin, J.; Song, L. Tetrahedron Lett. 2012, 53, 2160; (e) Weil, T.; 
Schreiner, P. R. Eur. J. Org. Chem. 2005, 2005, 2213; (f) Schmidt, E. Y.; Bidusenko, I. A.; 
Cherimichkina, N. A.; Ushakov, I. A.; Trofimov, B. A. Tetrahedron 2016, 72, 4510. 
3. (a) Peshkov, V. A.; Pereshivko, O. P.; Eycken, E. V. V. der. Chem. Soc. Rev. 2012, 41, 
3790; (b) Watson, M. P.; Maity, P. Synlett 2012, 23, 1705; (c) Yamada, K.; Tomioka, K. Chem. 
Rev. 2008, 108, 2874; (d) Li, C.-J. Acc. Chem. Res. 2010, 43, 581; (e) Ljungdahl, N.; Kann, N. 
Angew. Chem. Int. Ed. 2009, 48, 642. 
4. (a) Lazreg, F.; Lesieur, M.; Samson, A. J.; Cazin, C. S. J. ChemCatChem 2016, 8, 209; 
(b) Fu, X.-P.; Liu, L.; Wang, D.; Chen, Y.-J.; Li, C.-J. Green Chem. 2011, 13, 549; (c) Yu, M.; 
Skouta, R.; Zhou, L.; Jiang, H.; Yao, X.; Li, C.-J. J. Org. Chem. 2009, 74, 3378. 
5. Takita, R.; Fukuta, Y.; Tsuji, R.; Ohshima, T.; Shibasaki, M. Org. Lett. 2005, 7, 1363. 
6. (a) Xu, M.-H.; Pu, L. Org. Lett. 2002, 4, 4555; (b) Tan, L.; Chen, C.; Tillyer, R. D.; 
Grabowski, E. J. J.; Reider, P. J. Angew. Chem. Int. Ed. 1999, 38, 711; (c) Trost, B. M.; Bartlett, 
M. J.; Weiss, A. H.; von Wangelin, A. J.; Chan, V. S. Chem. Eur. J. 2012, 18, 16498; (d) 
Haidzinskaya, T.; Kerchner, H. A.; Liu, J.; Watson, M. P. Org. Lett. 2015, 17, 3857; (e) Cook, 
A. M.; Wolf, C. Angew. Chem. Int. Ed. 2016, 55, 2929; (f) Sempere Molina, Y.; Ruchti, J.; 
12 
 
Carreira, E. M. Org. Lett. 2017, 19, 743; (g) Wu, H.-L.; Wu, P.-Y.; Cheng, Y.-N.; Uang, B.-J. 
Tetrahedron 2016, 72, 2656; (h) Huang, W.-C.; Liu, W.; Wu, X.-D.; Ying, J.; Pu, L. J. Org. 
Chem. 2015, 80, 11480; (i) Bauer, T. Coord. Chem. Rev. 2015, 299, 83; (j) Wang, M.-C.; Zhang, 
Q.-J.; Zhao, W.-X.; Wang, X.-D.; Ding, X.; Jing, T.-T.; Song, M.-P. J. Org. Chem. 2008, 73, 
168; (k) Frantz, D. E.; Fässler, R.; Carreira, E. M. J. Am. Chem. Soc. 2000, 122, 1806; (l) Frantz, 
D. E.; Fässler, R.; Tomooka, C. S.; Carreira, E. M. Acc. Chem. Res. 2000, 33, 373. 
7. Shao, Y.; Zhang, F.; Zhang, J.; Zhou, X. Angew. Chem. Int. Ed. 2016, 55, 11485. 
8. (a) Wei, C.; Li, C.-J. J. Am. Chem. Soc. 2003, 125, 9584; (b) Oña-Burgos, P.; Fernández, 
I.; Roces, L.; Torre Fernández, L.; García-Granda, S.; López Ortiz, F. Organometallics 2009, 28, 
1739; (c) Wachenfeldt, H. v.; Röse, P.; Paulsen, F.; Loganathan, N.; Strand, D. Chem. Eur. J. 
2013, 19, 7982; (d) Kung, K. K.-Y.; Lo, V. K.-Y.; Ko, H.-M.; Li, G.-L.; Chan, P.-Y.; Leung, K.-
C.; Zhou, Z.; Wang, M.-Z.; Che, C.-M.; Wong, M.-K. Adv. Synth. Catal. 2013, 355, 2055; (e) 
Campbell, M. J.; Toste, F. D. Chem. Sci. 2011, 2, 1369; (f) Cheng, M.; Zhang, Q.; Hu, X.-Y.; Li, 
B.-G.; Ji, J.-X.; Chan, A. S. C. Adv. Synth. Catal. 2011, 353, 1274; (g) Suzuki, Y.; Naoe, S.; 
Oishi, S.; Fujii, N.; Ohno, H. Org. Lett. 2012, 14, 326; (h) Zhang, Q.; Cheng, M.; Hu, X.; Li, B.-
G.; Ji, J.-X. J. Am. Chem. Soc. 2010, 132, 7256; (i) Li, J.; Liu, L.; Ding, D.; Sun, J.; Ji, Y.; Dong, 
J. Org. Lett. 2013, 15, 2884; (j) Yadav, J. S.; Reddy, B. V. S.; Yadav, N. N.; Gupta, M. K.; 
Sridhar, B. J. Org. Chem. 2008, 73, 6857; (k) Lo, V. K.-Y.; Liu, Y.; Wong, M.-K.; Che, C.-M. 
Org. Lett. 2006, 8, 1529; (l) Villaverde, G.; Corma, A.; Iglesias, M.; Sánchez, F. ACS Catal. 
2012, 2, 399; (m) Li, Q.; Das, A.; Wang, S.; Chen, Y.; Jin, R. Chem. Commun. 2016, 52, 14298; 
(n) Aguilar, D.; Contel, M.; Urriolabeitia, E. P. Chem. Eur. J. 2010, 16, 9287; (o) Li, J.; Wang, 
H.; Sun, J.; Yang, Y.; Liu, L. Org. Biomol. Chem. 2014, 12, 2523; (p) Price, G. A.; Brisdon, A. 
13 
 
K.; Flower, K. R.; Pritchard, R. G.; Quayle, P. Tetrahedron Lett. 2014, 55, 151; (q) Zhang, X.; 
Corma, A. Angew. Chem. Int. Ed. 2008, 47, 4358. 
9. (a) Hashimoto, T.; Omote, M.; Maruoka, K. Angew. Chem. Int. Ed. 2011, 50, 8952; (b) 
Paioti, P. H. S.; Abboud, K. A.; Aponick, A. J. Am. Chem. Soc. 2016, 138, 2150; (c) Sugiishi, T.; 
Kimura, A.; Nakamura, H. J. Am. Chem. Soc. 2010, 132, 5332; (d) Li, Z.; Li, C.-J. J. Am. Chem. 
Soc. 2004, 126, 11810; (e) Yamamoto, Y.; Hayashi, H.; Saigoku, T.; Nishiyama, H. J. Am. 
Chem. Soc. 2005, 127, 10804; (f) Zhao, C.; Seidel, D. J. Am. Chem. Soc. 2015, 137, 4650; (g) 
Gommermann, N.; Koradin, C.; Polborn, K.; Knochel, P. Angew. Chem. Int. Ed. 2003, 42, 5763; 
(h) Wei, C.; Li, C.-J. J. Am. Chem. Soc. 2002, 124, 5638; (i) Han, J.; Xu, B.; Hammond, G. B. J. 
Am. Chem. Soc. 2010, 132, 916; (j) Lu, Y.; Johnstone, T. C.; Arndtsen, B. A. J. Am. Chem. Soc. 
2009, 131, 11284; (k) Cai, Y.; Tang, X.; Ma, S. Chem. Eur. J. 2016, 22, 2266; (l) Das, D.; Sun, 
A. X.; Seidel, D. Angew. Chem. 2013, 125, 3853; (m) Fan, W.; Yuan, W.; Ma, S. Nature 
Commun. 2014, 5, 3884. 
10. (a) Vandavasi, J. K.; Hu, W.-P.; Boominathan, S. S. K.; Guo, B.-C.; Hsiao, C.-T.; Wang, 
J.-J. Chem. Commun. 2015, 51, 12435; (b) Li, H.; Loh, T.-P. J. Am. Chem. Soc. 2008, 130, 7194; 
(c) Stekrova, M.; Mäki-Arvela, P.; Kumar, N.; Behravesh, E.; Aho, A.; Balme, Q.; Volcho, K. 
P.; Salakhutdinov, N. F.; Murzin, D. Y. J. Mol. Cat. A: Chem. 2015, 410, 260; (d) Jasti, R.; 
Rychnovsky, S. D. J. Am. Chem. Soc. 2006, 128, 13640; (e) Spivey, A. C.; Laraia, L.; Bayly, A. 
R.; Rzepa, H. S.; White, A. J. P. Org. Lett. 2010, 12, 900; (f) Subba Reddy, B. V.; 
Venkateswarlu, A.; Borkar, P.; Yadav, J. S.; Sridhar, B.; Grée, R. J. Org. Chem. 2014, 79, 2716. 
11. (a) Trost, B. M.; Weiss, A. H. Angew. Chem. Int. Ed. 2007, 46, 7664; (b) Roethle, P. A.; 
Trauner, D. Org. Lett. 2006, 8, 345; (c) Trost, B. M.; Mueller, T. J. J.; Martinez, J. J. Am. Chem. 
Soc. 1995, 117, 1888; (d) Takada, H.; Kumagai, N.; Shibasaki, M. Org. Lett. 2015, 17, 4762; (e) 
14 
 
Kona, C. N.; Ramana, C. V. Tetrahedron 2014, 70, 3653; (f) Alagiri, K.; Furutachi, M.; 
Yamatsugu, K.; Kumagai, N.; Watanabe, T.; Shibasaki, M. J. Org. Chem. 2013, 78, 4019. 
12. Salvador, R. L.; Simon, D. Can. J. Chem. 1966, 44, 2570. 
13. Asano, Y.; Hara, K.; Ito, H.; Sawamura, M. Org. Lett. 2007, 9, 3901. 
14. Motoki, R.; Kanai, M.; Shibasaki, M. Org. Lett. 2007, 9, 2997. 
15. Wang, L.; Liu, N.; Dai, B.; Ma, X.; Shi, L. RSC Adv. 2015, 5, 10089. 
16. Czerwiński, P.; Molga, E.; Cavallo, L.; Poater, A.; Michalak, M. Chem. Eur. J. 2016, 22, 
8089. 
17. Xu, N.; Gu, D.-W.; Zi, J.; Wu, X.-Y.; Guo, X.-X. Org. Lett. 2016, 18, 2439. 
18. Chen, Q.; Tang, Y.; Huang, T.; Liu, X.; Lin, L.; Feng, X. Angew. Chem. Int. Ed. 2016, 
55, 5286. 
19. Maity, P.; Srinivas, H. D.; Watson, M. P. J. Am. Chem. Soc. 2011, 133, 17142. 
20. Srinivas, H. D.; Maity, P.; Yap, G. P. A.; Watson, M. P. J. Org. Chem. 2015, 80, 4003. 
21. Dasgupta, S.; Rivas, T.; Watson, M. P. Angew. Chem. Int. Ed. 2015, 54, 14154. 
22. Yao, X.; Li, C.-J. Org. Lett. 2006, 8, 1953. 
23. Obradors, C.; Echavarren, A. M. Chem. Eur. J. 2013, 19, 3547. 
24. (a) Ueda, H.; Yamaguchi, M.; Kameya, H.; Sugimoto, K.; Tokuyama, H. Org. Lett. 2014, 
16, 4948; (b) Ueda, H.; Yamaguchi, M.; Tokuyama, H. Chem. Pharm. Bull. 2016, 64, 824. 
25. Michalska, M.; Songis, O.; Taillier, C.; Bew, S. P.; Dalla, V. Adv. Synth. Catal. 2014, 
356, 2040. 
26. González, J.; Santamaría, J.; Ballesteros, A. Angew. Chem. Int. Ed. 2015, 54, 13678. 
  
15 
 
 
 
 
CHAPTER 2 
GOLD-CATALYZED HYDROALKYNYLATION OF VINYL ETHERS 
 
2.1 Introduction 
Some passages and figures in this chapter have been quoted from the following source: 
Hosseyni, S.; Smith, C. A.; Shi, X. Org. Lett. 2016, 18, 6336. 
Activation of alkenes and alkynes mediated by gold catalysis has enriched the field of 
synthetic chemistry by providing new synthetic strategies.1 Due to gold’s innate bonding 
properties, cationic Au(I) demonstrates an increased π-acid reactivity towards alkynes in 
comparison with alkenes. This disparate reactivity is exhibited by the gold-catalyzed enyne 
cycloisomerization reaction, wherein gold preferentially activates a terminal alkyne towards 
nucleophilic attack by the alkene. Enyne cycloisomerization reactions have proven amenable to a 
variety of substrates and are a powerful strategy for installing complex molecular scaffolds 
(Figure 2.1).2  
 
 
Figure 2.1. Compounds synthesized using gold-catalyzed enyne cycloisomerization. 
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One constituent of this class of reactions is the intermolecular enyne  cycloisomerization 
of alkenes and alkynes, as reported by Echavarren and coworkers.3 This reaction culminates with 
gold-activation of the terminal alkyne and subsequent alkene nucleophilic addition. The 
intermediate undergoes ring expansion and elimination to form the final cyclobutene product. 
(Figure 2.2).   
 
 
    Figure 2.2. Mechanism of gold-catalyzed enyne cycloisomerization. 
 
This reaction facilitates access to the cyclobutene skeleton and has been used for 
macrocycle ring formation4, as well as for the total synthesis of naturally-occurring compounds.5 
Based on these previous studies, and because vinyl ethers had yet to be utilized as the alkene 
source, we reasoned whether vinyl ethers would react in a manner analogous to the well-
established enyne cycloisomerization reaction (Figure 2.3). 
 
 
Figure 2.3. Proposed intermolecular reaction of vinyl ethers and terminal alkynes. 
 
17 
 
However, in comparison with regular alkenes, vinyl ethers consist of a more electron-rich 
π-system resulting from oxygen’s donation of electron-density. Although the additional electron-
density may increase the nucleophilicity of the π-system, this density may also promote 
decomposition (e.g. polymerization) of the substrate in the presence of acidic counterparts.6 
Furthermore, the substantiated electron-density may lead to decomposition of [L-Au]+. 
In 2016, Shi and coworkers developed a triazole (TA)-gold catalyzed enyne 
cycloisomerization of homopropargyl alcohols and terminal aliphatic alkynes.7 In this study, they 
postulated that the presence of the vinyl ether intermediate led to the observed decomposition of 
[L-Au]+. However, equipping the Au catalyst with a stabilizing triazole ligand successfully 
decreased catalyst decomposition (Figure 2.4). Thus, we hypothesized that TA-Au may be viable 
in our proposed vinyl ether hydroalkynylation reaction.8 
 
           
Figure 2.4. Reported cycloisomerization of homo-propargyl alcohols and alkynes. 
 
2.2 Results and Discussion 
2.2.1 Monitoring Catalyst Decomposition 
The investigation was initiated by evaluating the stability of gold catalysts in the reaction 
system, as vinyl ether 51a and two equivalents of terminal alkyne 52a were reacted in the 
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presence of 5% PPh3AuNTf2 at ambient temperature. 
1H-Nuclear Magnetic Resonance (NMR) 
Spectroscopy of the crude after completion revealed that the major product formed was 54a, 
which arises from C-2 hydroalkynylation of the vinyl ether (Figure 2.5). Notably, this result 
contrasts with the expected fused cyclobutene 53a that is formed via enyne cycloisomerization. 
Expectedly, monitoring the reaction via 31P-NMR indicated quantitative decomposition of the 
gold catalyst over 30 minutes.9 Thus, 5% [PPh3Au(TA-H)]OTf was used to test the hypothesis 
that the stability conferred by the TA-Au is central to reaction performance. Gold decomposition 
was significantly lowered, as hypothesized, to less than 10% and the yield of the 
hydroalkynylation product was increased to 48%. To further optimize the yield of the desired 
product, a detailed screening of the reaction conditions was conducted (Table 2.1). For 
comprehensive screening conditions, see Table 2.4. 
 
 
Figure 2.5. Initial investigation of catalyst stability. 
 
2.2.2 Screening of Catalytic Conditions 
A modest amount of 54a was formed when triphenylphosphine was used as the primary 
ligand (24%; entry 1, Table 2.1). Although the electron-rich ligands IPrAuNTf2 (10%; entry 2, 
Table 2.1), or XPhosAuNTf2 (16%; entry 3, Table 2.1) led to diminished yields, using an 
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electron-deficient phosphite ligand increased the yield to 44% (entry 4, Table 2.1). This result 
may arise from the increased electrophilicity of the gold cation bearing the electron-withdrawing 
phosphite ligand.  
 
Table 2.1. Screening of conditions for TA-Au catalyzed hydroalkynylation. 
 
 
 
Catalyst 
Time 
(h) 
Conv 
(%) 
Yieldb (%) 
1 3% PPh3AuNTf2 2 100 24 
2 3% IPrAuNTf2 2 100 <10 
3 3% XPhosAuNTf2 2 100 16 
4 3% (ArO)3PAuNTf2
 c 2 100 44 
5 3% (ArO)3PAu(TA-H)OTf
 c 4 100 54 
6 3% (ArO)3PAu(TA-Ph)OTf
 c 4 100 56 
7 3% (ArO)3PAu(TA-Ph)OTf
 c  
(51a was added slowly over 3 hr) 
 
6 100 78 
8 Other tested catalysts (5%): CuI, Cu(OTf)2, 
Ga(OTf)3, ZnBr2, HOTf etc. (see SI) 
 
6 100 Trace 
9 Other tested solvents: toluene, CH3CN, THF, 
MeNO2  
6 100 <50% 
 
 
a  Reaction conditions: To a solution of 51a (1 mmol) and 52a (2 mmol) in CDCl3 (1.33 mL), catalyst was added and stirred 
at room temperature. b 1H NMR yields were calculated using 1,3,5-trimethoxybenzene as an internal standard. c Ar = 2,4-Di-
tButylbenzene. 
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Subsequently, the increased electrophilicity may increase gold’s tendency to interact with 
the acetylide anion to form gold acetylide 56. Employing triazole-gold led to a further increase in 
the yields, likely attributed to the stability conferred by the triazole ligand (entries 5-6, Table 
2.1). 
Unexpectedly, when 1H-NMR was used to monitor the reaction progression, a side-
product formed that arose from self-condensation of the vinyl ether. To rationalize this side-
reaction, it can be suggested that the electron-rich vinyl ether 1a may nucleophilically interact 
with the electrophilic intermediate 55. Furthermore, gold complexes of vinyl ethers characterized 
by η2 complexation have been isolated and fully characterized by Jones and coworkers.10 In 
support of this gold-promoted dimerization, 51a converts to the dimerization product in the 
presence of solely TA-Au. To diminish this self-condensation pathway and increase the yield of 
the desired product, the concentration of 51a was decreased by adding the reagent dropwise to 
the reaction mixture over a period of 3 hours (entry 7; 78%, Table 2.1). Despite the existence of 
well-established copper-catalyzed hydroalkynylation reactions of iminium intermediates, the use 
of copper(I/II) salts was not able to furnish the desired product. Additional metal catalysts or 
acids such as triflic acid, zinc(II)bromide, and gallium(III)triflate, were also not able to promote 
the transformation.  
 
2.2.3 Substrate Scope of Hydroalkynylation 
Next, the substrate scope of the vinyl ether hydroalkynylation reaction was investigated 
(Table 2.2). When 2H-pyran or 2H-furan are used, the reaction has a broad scope and is tolerated 
by phenylacetylene derivatives bearing both electron-deficient (54b, 54c, 54o) and electron-rich 
(54d, 54e, 54m) functional groups at varying substitutions. Furthermore, the selective mono-
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alkynylation product 54i can be furnished from meta-diethynylbenzene in 58% yield, and the 
heteroaromatic thiophenyl derivative 54j is afforded in 73% yield. To illustrate the tolerance of 
the reaction towards alkenes, a conjugated enyne was used and proved to be a viable substrate 
for the reaction (54h). In addition, aliphatic alkynes bearing cyclopropyl and cyclopentyl 
substituents reacted similarly (54f, 54g).  
 
Table 2.2. Scope of vinyl ether hydroalkynylation. 
 
 
A variety of vinyl ethers were also able to undergo the desired hydroalkynylation 
reaction, with the reaction conditions tolerating both cyclic (54a-54j; 54n-54q) and linear (54k-
54m) ethers. However, when mono-substituted vinyl ethers were subjected to the reaction, the 
desired products were formed in yields less than 30%. This disparate reactivity may be due to 
vinyl ether polymerization or the increased reactivity of these starting materials. On the other 
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hand, tri-substituted vinyl ethers were tolerated well, conversely due to the formation of less 
side-products in comparison with di- and mono- substituted vinyl ethers. Tetra-substituted vinyl 
ethers did not react to form the desired product, presumably due to the low reactivity resulting 
from their inherent steric hindrance. Finally, when aromatic vinyl ethers such as furan and 
benzofuran substrates were used, low conversion of the starting material was demonstrated. 
Overall, this reaction tolerated a wide range of both alkynes and vinyl ethers. 
 
2.2.3 Ferrier-Alkynylation Reaction of Glycals 
To expand the substrate scope of this chemistry, we reasoned whether carbohydrates 
bearing a vinyl ether moiety could be utilized. In fact, gold catalysis has been recently used for a 
variety of carbohydrate synthetic manipulations such as glycosylation and oxidation.11 Glycals, 
which bear a vinyl ether moiety, were identified as a suitable substrate for the reaction at hand.  
 
          
Figure 2.6. Application of copper methodology to simple vinyl ethers. 
 
Recent reports of a Lewis acid-promoted alkynylation and Ferrier-type elimination of 
glycal 57a have been realized by employing a combination of copper(II)triflate and ascorbic 
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acid.12 When attempting to apply this methodology towards 2H-pyrans, no alkynylation product 
was observed (Figure 2.6). Instead, rapid decomposition of the vinyl ether was observed via 1H-
NMR monitoring.  
 
Table 2.3. Scope of glycal hydroalkynylation-Ferrier elimination. 
        
 
To broaden the scope of the gold-catalytic methodology to encompass these glycal 
derivatives, we subjected various substrates to the optimized conditions to obtain the 
hydroalkynylation-Ferrier products. Unlike the reaction with un-functionalized vinyl ethers, the 
reaction with glycals required high temperature (70° Celsius) to promote full conversion of the 
starting material. Under these improved conditions, moderate to excellent yields of 58a were 
obtained, with a sole diastereomer produced for the majority of the glycal derivatives (Table 2.3). 
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Due to the glycal diasteromers being well-characterized in the literature, the dr was determined 
via 1H-NMR and the relative stereochemistry of the C-2 and C-6 positions were similarly 
assigned.13 
Gratifyingly, the reaction conditions tolerated a variety of glycals bearing various 
functional groups. For example, glycals with -OAc (58a-58f, Table 2.3), -OBn (58i, Table 2.3), 
or -OBz (58l, Table 2.3) at the C-3 position were well tolerated. Silyl ethers were also 
compatible, as glycals with an -OTBS group at the C-3 position were effectively functionalized 
(58j-58k, Table 2.3). The absence of the -OAc substituent at C-6 did not considerably affect the 
yield or stereochemistry of the products, as substrates bearing a methyl group at the position 
reacted analogously (58g-58h, Table 2.3).  As further illustration of the functional group 
tolerance of the transformation, the cholesterol derivative 58m was formed in moderate yield 
(64%). Despite the broad scope of the reaction, aliphatic alkynes could not be employed in the 
reaction.  
 
2.2.4 Mechanistic Investigations 
To explore the mechanism of the reaction, gold acetylide C was synthesized due to its 
putative role in the catalytic cycle. Vinyl ether 51a and gold-acetylide C were reacted under a 
variety of conditions to offer insight into the mechanism (Figure 2.7).  
In the presence of a catalytic amount of HOTf, 51a rapidly decomposes and 54a is not 
detected (eq 1).  Subjecting 51a to stoichiometric (1 equiv) gold-acetylide C in the absence of 
Lewis acid led to no conversion of 51a (eq 2).  Adding a catalytic amount of PPh3AuNTf2 (10%) 
to an equimolar mixture of gold-acetylide C and vinyl ether 51a led to decomposition of both the 
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gold and vinyl ether substrate (eq 3).  Employing the triazole gold catalyst [(ArO)3PAu(TA-
Ph)]OTf decreased the yield appreciably (eq 4).  However, a combination of 2% HOTf in the 
presence of stoichiometric gold-acetylide C was sufficient to promote the transformation of vinyl 
ether 51a to the desired product 54a (eq 5).14 
 
 
Figure 2.7. Mechanistic investigation of vinyl ether hydroalkynylation. 
 
These mechanistic studies constitute evidence that the gold-acetylide acts as a 
nucleophile towards the in-situ generated oxocarbenium ion. Gold(I) association of terminal 
alkynes via sigma-binding is rare in the literature.15 Thus, this transformation serves to increase 
the diversity of these class of reactions. Furthermore, the results demonstrate that stability 
conferred by the triazole ligand is essential to the reaction design.  
 
2.3 Experimental Section 
Unless otherwise noted, all reagents and solvents were obtained from a commercial 
provider and used without further purification. All solvent was dried using sodium sulfate prior 
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to use. 1H- and 13C-NMR data was recorded on an Agilent 400 or 500 MHz NMR spectrometer. 
Chemical shifts for starting materials and products were recorded relative to internal TMS (0.00 
ppm) for 1H-NMR and CDCl3 (77.00 ppm) for 13C-NMR data. Flash column chromatography 
was performed on 230-430 mesh silica gel. Analytical thin layer chromatography was performed 
with pre- coated, glass-baked plates (250μ) and visualized by fluorescence or charring with 
potassium permanganate stain. High-resolution mass spectra were recorded on a LTQ-FTUHRA 
spectrometer. 
 
Table 2.4. Comprehensive screening table of catalytic hydroalkynylation. 
 
Entry cat. Time (h) 
 
Conv. (%) 
 
Yield 54a (%) 
  
1  3% PPh3AuNTf2 2 100 24 
2 3% IPrAuNTf2 2 100 <10 
3 3% XPhosAuNTf2 2 100 16 
4  3% (ArO)3PAuNTf2  2 100 44 
5 3% SPhosAuNTf2 2 100 10 
7 3% RuPhosAuNTf2  2 100 10 
8 3% PPh3Au(TA-H)OTf 7 100 44 
9 3% PPh3Au(TA-Me)OTf  7 100 46 
10 3% PPh3Au(NCCH3)OTf  7 100 40 
11 3% XPhosAu(TA-H)OTf  7 100 33 
12 3%  (ArO)3PAu(TA-H)OTf  5 100 54 
13 3%  (ArO)3PAu(TA-Me)OTf  5 100 56 
15  3%  (ArO)3PAu(TA-Ph)OTf  
(51a added slowly over 3 hrs) 
6 100 78 
16 5% AgOTf 7 - <10 
17 5% CuI  7 <10 0 
18 5% Cu(OTf)2  7 - 0 
19 5% Cu(OAc)2  7 - 0 
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Table 2.4. (Continued) Comprehensive screening table of catalytic hydroalkynylation. 
Entry cat. Time (h) 
 
Conv. (%) 
 
Yield 54a (%) 
  
20 10% Cu(OTf)2/Ascorbic acid  2 min 100 trace 
21 5% ZnBr2  7 - 0 
22 5% HOTf 2 min 100 0 
23 5% Ga(OTf)3 7 - 0 
 
 
 
Figure 2.8. Procedure for synthesis of tri-arylphosphite gold-acetylide C. 
 
A 20 mL oven-dried screw-cap vial was charged with (ArO)3PAuCl (880 mg, 1 mmol) in 
dry DCM (10 mL) and placed under argon atmosphere. AgOAc (184 mg, 1.1 mmol) was then 
added while stirring. The vial was covered with foil and stirred at ambient temperature for 4 
hours. The reaction mixture was slowly filtered through a pad of celite into a separate oven-dried 
vial. The celite pad was rinsed with an additional 20 mL DCM. The combined filtrate was 
concentrated in vacuo to afford the solid product B. To the compound B was added 20 mL of dry 
DCM followed by phenylacetylene (168 µL, 1.5 mmol). The reaction mixture was then stirred 
for 30 minutes under argon atmosphere. The reaction mixture was slowly filtered through a pad 
of celite. The resulting solution was concentrated in vacuo and placed on hi-vac for at least 4 
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hours to remove DCM, excess phenylacetylene and acetic acid. The resulting colorless oil C was 
directly used for the reactions.  
The gold complex C was obtained in 92% isolated yield (869 mg) 
as a colorless oil. 1H NMR (400 MHz; CDCl3): δ 7.49-7.41 (m, 
8H), 7.32-7.30 (m, 1H), 7.20-7.12 (m, 5H), 1.45 (s, 27H), 1.29 (s, 
27H). 13C NMR (126 MHz; CDCl3) δ 147.6, 147.4, 139.0, 132.3, 
132.1, 128.7, 128.3, 127.9, 127.0, 125.1, 124.1, 119.3, 35.0, 34.6, 31.4, 30.5. 31P NMR (162 
MHz; CDCl3): δ 131.0. HRMS calculated for C50H69AuO3P [M+H]+: 945.4572, Found: 
945.4579. 
 
2.3.1 General Procedure for Synthesizing Compounds 54 
To a 2 mL vial, gold catalyst (31 mg, 0.03 mmol) was added to a solution of 52a (204 
mg, 2 mmol) in CHCl3 (0.70 mL) under ambient air. The resulting reaction mixture was stirred 
and 51a (84 mg, 1 mmol) in 0.63 mL of CHCl3 was added slowly via syringe pump over 3 hours 
to the mixture.  The resulting mixture was stirred at room temperature for an additional 3 hours. 
The reaction mixture was then directly loaded on column chromatography using silica gel for 
purification and hexane/ethyl acetate (20:1) as eluent to isolate the desired product. 
54a was obtained using general procedure A in 78% isolated yield (146 
mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR 
(400 MHz; CDCl3): δ 7.45 (m, 2H), 7.29 (m, 3H), 4.51 (dd, J = 7.8, 2.9 
Hz, 1H), 4.07-4.03 (m, 1H), 3.59 (ddd, J = 11.7, 8.4, 3.3 Hz, 1H), 1.95-1.90 (m, 2H), 1.82-1.78 
(m, 1H), 1.64-1.58 (m, 3H). 13C NMR (126 MHz; CDCl3): δ 131.7, 128.24, 128.17, 122.7, 88.1, 
C 
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85.2, 67.4, 66.6, 32.2, 25.7, 21.8. HRMS calculated for C13H15O [M+H]+: 187.1045, Found: 
187.1041. The characterization data is consistent with the literature.1 
54b was obtained using general procedure A in 76% isolated yield (168 
mg) as a pale yellow oil. (Elution: ethyl acetate/hexanes = 1/20). 1H 
NMR (500 MHz; CDCl3): δ 7.44-7.43 (m, 1H), 7.34-7.28 (m, 2H), 
7.24-7.21 (m, 1H), 4.50 (dd, J = 7.9, 2.9 Hz, 1H), 4.05-4.03 (m, 1H), 3.61-3.57 (m, 1H), 1.94-
1.89 (m, 2H), 1.80-1.75 (m, 1H), 1.64-1.59 (m, 3H). 13C NMR (126 MHz; CDCl3) δ 134.0, 
131.6, 129.9, 129.4, 128.6, 124.4, 89.4, 83.8, 77.3, 67.3, 66.7, 32.0, 25.6, 21.8. HRMS 
calculated for C13H14ClO [M+H]+: 221.0655, Found: 221.0659. 
54c was obtained using general procedure A in 75% isolated yield (153.7 
mg) as a pale yellow oil. (Elution: ethyl acetate/hexanes = 1/20). 1H 
NMR (400 MHz; CDCl3): δ 7.27-7.23 (m, 2H), 7.15-7.13 (m, 1H), 7.04-
6.99 (m, 1H), 4.50 (dd, J = 7.9, 2.7 Hz, 1H), 4.06-4.01 (m, 1H), 3.62-3.56 (m, 1H), 1.94-1.89 (m, 
2H), 1.82-1.75 (m, 1H), 1.64-1.57 (m, 3H). 13C NMR (126 MHz; CDCl3) δ 162.3 (JC-F = 308.5 
Hz), 129.77 (JC-F = 10.87 Hz), 127.62 (JC-F = 4.12 Hz), 124.58 (JC-F = 11.87 Hz), 118.6 (JC-F = 
28.37 Hz), 115.6 (JC-F = 26.37 Hz), 89.1, 83.94 (JC-F = 4.5 Hz), 67.3, 66.7, 32.0, 25.6, 21.8. 
HRMS calculated for C13H14FO [M+H]+: 205.0950, Found: 205.0951. 
54d was obtained using general procedure A in 82% isolated yield 
(199 mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 1H 
NMR (500 MHz; CDCl3): δ 7.38 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.7 
Hz, 2H), 4.50 (dd, J = 7.8, 2.9 Hz, 1H), 4.05 (m, J = 3.4 Hz, 1H), 
3.60-3.56 (m, 1H), 1.93-1.89 (m, 2H), 1.81-1.77 (m, 1H), 1.63-1.57 (m, 3H), 1.30 (s, 9H). 13C 
                                                          
1 J. K. De Brabander, B. Liu, M. Qian, Org. Lett., 2008, 10, 2533.   
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NMR (126 MHz; CDCl3) δ 151.5, 131.4, 125.2, 119.7, 87.4, 85.3, 67.5, 66.6, 34.7, 32.2, 31.1, 
25.7, 21.8. HRMS calculated for C17H23O [M+H]+: 243.1671, Found: 243.1668. 
54e was obtained using general procedure A in 73% isolated yield 
(158.5 mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 
1H NMR (400 MHz; CDCl3): δ 7.38 (d, J = 8.9 Hz, 2H), 6.82 (d, J = 
8.9 Hz, 2H), 4.48 (dd, J = 8.0, 2.9 Hz, 1H), 4.07-4.02 (m, 1H), 3.80 (s, 3H), 3.60-3.55 (m, 1H), 
1.93-1.88 (m, 2H), 1.80-1.74 (m, 1H), 1.63-1.56 (m, 3H). 13C NMR (126 MHz; CDCl3) δ 159.5, 
133.2, 114.8, 113.8, 86.7, 85.0, 67.5, 66.6, 55.2, 32.3, 25.7, 21.9. HRMS calculated for C14H17O2 
[M+H]+: 217.1150, Found: 217.1153. 
54f was obtained using general procedure A in 70% isolated yield (106 mg) as 
a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR (500 MHz; 
CDCl3): δ 4.19 (dd, J = 6.2, 4.3 Hz, 1H), 3.96 (dt, J = 11.7, 3.8 Hz, 1H), 3.49-
3.45 (m, 1H), 1.80 (m, J = 3.0 Hz, 2H), 1.62-1.49 (m, 4H), 1.27-1.24 (m, 1H), 0.75 (m, 2H), 0.68 
(m, 2H). 13C NMR (126 MHz; CDCl3) δ 88.8, 74.4, 67.4, 66.7, 32.5, 25.6, 22.0, 8.2, -0.6. 
HRMS calculated for C10H15O [M+H]+: 151.1045, Found: 151.1049. 
54g was obtained using general procedure A in 68% isolated yield (122 mg) as 
a colorless oil (~5% impurity noted). (Elution: ethyl acetate/hexanes = 1/20). 
1H NMR (500 MHz; CDCl3): δ 4.22 (m, 1H), 3.97 (dt, J = 11.4, 3.8 Hz, 1H), 
3.50-3.46 (m, 1H), 2.66-2.60 (m, 1H), 1.90 (m, 2H), 1.84-1.78 (m, 2H), 1.69 (m, 2H), 1.63-1.51 
(m, 9H). 13C NMR (126 MHz; CDCl3) δ 90.0, 78.6, 67.4, 66.7, 33.8, 32.6, 30.1, 25.7, 24.9, 22.0. 
HRMS calculated for C12H19O [M+H]+: 179.1358, Found: 179.1361. 
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54h was obtained using general procedure A in 66% isolated yield (126 mg) 
as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR (400 
MHz; CDCl3): δ 6.06 (m, 1H), 4.33 (dd, J = 7.8, 2.7 Hz, 1H), 3.96-3.91 (m, 
1H), 3.49 (m, 1H), 2.09-2.02 (m, 4H), 1.82-1.77 (m, 2H), 1.62-1.50 (m, 8H). 13C NMR (126 
MHz; CDCl3) δ 135.0, 120.1, 87.0, 85.3, 67.4, 66.4, 32.3, 29.1, 25.63, 25.57, 25.54, 22.2, 21.8, 
21.4. HRMS calculated for C13H19O [M+H]+: 191.1358, Found: 191.1357. The characterization 
data is consistent with the literature.2 
54i was obtained using a modified general procedure A (3 equivalents 
of alkyne were used) in 58% isolated yield (122 mg) as a colorless oil. 
(Elution: ethyl acetate/hexanes = 1/20). 1H NMR (500 MHz; CDCl3): 
δ 7.58 (s, 1H), 7.43 (d, J = 1.6 Hz, 1H), 7.41 (d, J = 1.6 Hz, 1H), 7.26 (s, 1H), 4.50 (dd, J = 7.8, 
2.9 Hz, 1H), 4.05-4.03 (m, 1H), 3.61-3.57 (m, 1H), 3.07 (s, 1H), 1.93-1.89 (m, 2H), 1.80-1.77 
(m, 1H), 1.64-1.58 (m, 3H). 13C NMR (126 MHz; CDCl3) δ 135.3, 132.00, 131.84, 128.3, 123.1, 
122.3, 88.9, 84.2, 82.7, 77.7, 67.3, 66.6, 32.1, 25.6, 21.8. HRMS calculated for C15H15O 
[M+H]+: 211.1045, Found: 211.1048. 
54j was obtained using general procedure A in 73% isolated yield (141 mg) 
as a yellow oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR (400 MHz; 
CDCl3): δ 7.44 (d, J = 2.8 Hz, 1H), 7.26-7.23 (m, 1H), 7.11 (d, J = 5.0 Hz, 
1H), 4.48 (dd, J = 7.9, 2.5 Hz, 1H), 4.04 (dt, J = 11.4, 4.1 Hz, 1H), 3.57 (td, J = 10.0, 3.2 Hz, 
1H), 1.94-1.89 (m, 2H), 1.81-1.74 (m, 1H), 1.60 (m, 3H). 13C NMR (126 MHz; CDCl3) δ 129.9, 
128.9, 125.1, 121.7, 87.7, 80.2, 67.5, 66.7, 32.1, 25.6, 21.8. HRMS calculated for C11H13OS 
[M+H]+: 193.0609, Found: 193.0611. 
                                                          
2 M. Lin, et al., Synlett, 2011, 5, 665.   
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54k was obtained using general procedure A in 83% isolated yield (157 mg) as a 
colorless oil (~5% impurity noted). (Elution: ethyl acetate/hexanes = 1/20). 1H 
NMR (400 MHz; CDCl3): δ 7.45-7.43 (m, 2H), 7.30 (m, 3H), 4.19 (t, J = 6.5 Hz, 
1H), 3.89-3.85 (m, 1H), 3.53-3.49 (m, 1H), 1.87-1.80 (m, 2H), 1.26 (d, J = 14.1 
Hz, 3H), 1.07 (d, J = 14.9 Hz, 3H). 13C NMR (126 MHz; CDCl3) δ 131.7, 128.21, 128.16, 122.9, 
88.6, 85.4, 71.2, 64.3, 29.0, 15.2, 9.8. HRMS calculated for C13H17O [M+H]+: 189.1201, Found: 
189.1188. 
54l was obtained using general procedure A in 80% isolated yield (178.5 mg) as a 
pale yellow oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR (500 MHz; 
CDCl3): δ 7.42 (s, 1H), 7.30-7.23 (m, 3H), 4.17 (t, J = 6.5 Hz, 1H), 3.87-3.81 (dq, 
J = 9.2, 7.0 Hz, 1H), 3.50 (dq, J = 9.2, 7.0 Hz, 1H), 1.81 (m, 2H), 1.25 (t, J = 7.0 
Hz, 3H), 1.05 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz; CDCl3) δ 134.0, 131.6, 129.8, 129.4, 
128.5, 124.6, 90.0, 84.0, 71.1, 64.4, 28.9, 15.2, 9.8. HRMS calculated for C13H16ClO [M+H]+: 
223.0811, Found: 223.0815. 
54m was obtained using general procedure A in 85% isolated yield 
(208.5 mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 
1H NMR (500 MHz; CDCl3): δ 7.39-7.37 (m, 2H), 7.33-7.31 (m, 2H), 
4.18 (t, J = 6.5 Hz, 1H), 3.86 (dq, J = 9.2, 7.0 Hz, 1H), 3.50 (dq, J = 9.2, 7.0 Hz, 1H), 1.85-1.78 
(m, 2H), 1.30 (s, 9H), 1.25 (t, J = 14.1 Hz, 3H), 1.06 (t, J = 14.9 Hz, 3H). 13C NMR (126 MHz; 
CDCl3) δ 151.4, 131.4, 125.2, 119.9, 87.9, 85.5, 71.2, 64.2, 34.7, 31.2, 29.1, 15.2, 9.8. HRMS 
calculated for C17H25O [M+H]+: 245.1827, Found: 245.1881. 
54m 
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54n was obtained using general procedure A in 73% isolated yield (126 mg) 
as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR (500 
MHz; CDCl3): δ 7.43 (m, 2H), 7.29 (m, 3H), 4.82 (dd, J = 7.2, 5.0 Hz, 1H), 
4.01 (m, 1H), 3.86 (m, 1H), 2.25-2.20 (m, 1H), 2.11-2.06 (m, 2H), 1.95 (m, J = 2.7 Hz, 1H). 13C 
NMR (126 MHz; CDCl3) δ 131.7, 128.22, 128.18, 122.8, 89.0, 84.4, 68.6, 67.9, 33.4, 25.5. 
HRMS calculated for C12H13O [M+H]+: 173.0888, Found: 173.0892. The characterization data is 
consistent with the literature.3 
54o was obtained using general procedure A in 72% isolated yield (137.5 
mg) as a pale yellow oil. (Elution: ethyl acetate/hexanes = 1/20). 1H 
NMR (500 MHz; CDCl3): δ 7.26-7.20 (m, 2H), 7.13 (m, 1H), 7.01 (m, 
1H), 4.82-4.79 (m, 1H), 4.01 (m, 1H), 3.87 (m, 1H), 2.27-2.21 (m, 1H), 2.13-2.06 (m, 2H), 1.99-
1.93 (m, 1H). 13C NMR (126 MHz; CDCl3) δ 162.2 (JC-F = 245.12 Hz), 129.77 (JC-F = 8.62 Hz), 
127.58 (JC-F = 3.12 Hz), 124.64 (JC-F = 9.5 Hz), 118.50 (JC-F = 22.62 Hz), 115.61 (JC-F = 21.12 
Hz), 90.1, 83.23 (JC-F = 4.12 Hz), 68.5, 68.0, 33.3, 25.5. HRMS calculated for C12H12FO 
[M+H]+: 191.0794, Found: 191.0809. The characterization data is consistent with the literature.4 
54p was obtained using general procedure A in 91% isolated yield (196 mg) 
as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR (500 
MHz; CDCl3): δ 7.46-7.44 (m, 2H), 7.31-7.30 (m, 3H), 3.44 (s, 3H), 2.01 (m, 
2H), 1.71 (m, 2H), 1.67-1.54 (m, 6H). 13C NMR (126 MHz; CDCl3) δ 131.7, 
                                                          
3 D. S. Daniels, A. L. Thompson, E. A. Anderson, Agnew. Chem., 2011, 50, 11506.   
4 J. Zhang, P. Li, L. Wang, Org. Biomol. Chem., 2014, 12, 2969.   
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128.20, 128.09, 123.0, 90.3, 86.1, 74.4, 50.8, 36.8, 25.5, 22.9. HRMS calculated for C15H19O 
[M+H]+: 215.1358, Found: 215.1360. The characterization data is consistent with the literature.5 
54q was obtained using general procedure A in 93% isolated yield (252 
mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/20). 1H NMR 
(400 MHz; CDCl3): δ 7.38-7.36 (m, 2H), 7.32-7.30 (m, 2H), 3.41 (s, 3H), 
2.00-1.97 (m, 2H), 1.70-1.53 (m, 8H), 1.29 (s, 9H). 13C NMR (126 MHz; 
CDCl3) δ 151.4, 131.4, 125.2, 120.0, 89.5, 86.2, 74.4, 50.7, 36.9, 34.7, 31.2, 25.5, 22.9. HRMS 
calculated for C19H27O [M+H]+: 271.1984, Found: 271.1985. 
 
2.3.2 General Procedure for Synthesizing Compounds 58 
 
 
To a 2 mL vial, gold catalyst (31 mg, 0.03 mmol) was added to a solution of 52a (204 
mg, 2 mmol) in 1,2-dichloroethane (1.33 mL) under ambient air followed by addition of 57a 
(272.2 mg, 1 mmol). The resulting mixture was stirred at 70 oC for 4 hours. The reaction mixture 
was then directly loaded on column chromatography using silica gel for purification and 
hexane/ethyl acetate (5:1) as eluent to isolate the desired product. The stereochemistry of the 
glycal derivatives was assigned via 1H and 13C NMR analysis of the H-5 and C-5 coupling 
                                                          
5 M. Baxter, Y. Bolshan, Chem. Eur. J., 2015, 21, 13535.  
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constants and chemical shifts. This method of assignment is well established in the literature.6 
The diastereomeric ratio was determined via 1H NMR. 
58a was obtained using general procedure B in 71% isolated yield 
(224 mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/5); α:β 
= >99:1. 1H NMR (500 MHz; CDCl3): δ 7.46-7.44 (m, 2H), 7.35-7.32 
(m, 3H), 5.99 (ddd, J = 10.2, 3.5, 1.9 Hz, 1H), 5.83 (dt, J = 10.2, 1.9 Hz, 1H), 5.36-5.33 (dq, J = 
3.6, 1.9 Hz, 1H), 5.21 (m, 1H), 4.27 (d, J = 3.9 Hz, 2H), 4.20 (dt, J = 8.7, 4.2 Hz, 1H, H-5), 2.10 
(s, J = 0.5 Hz, 6H). 13C NMR (126 MHz; CDCl3) δ 170.9, 170.3, 131.8, 129.2, 128.7, 128.3, 
125.5, 122.2, 86.7, 84.7, 70.0, 64.8, 64.5, 63.1, 21.03, 20.83. HRMS calculated for C18H19O5 
[M+H]+: 315.1154, Found: 315.1152. The characterization data is consistent with the literature.7 
58b was obtained using general procedure B in 75% isolated 
yield (278.5 mg) as a colorless oil. (Elution: ethyl 
acetate/hexanes = 1/5); α:β = 98:2. 1H NMR (400 MHz; CDCl3): 
δ 7.39 (d, J = 8.6 Hz, 2H), 7.34 (d, J = 8.5 Hz, 2H), 5.98 (ddd, J 
= 10.1, 3.6, 1.9 Hz, 1H), 5.81 (dt, J = 10.2, 1.9 Hz, 1H), 5.34 (dq, J = 8.9, 2.0 Hz, 1H), 5.19 (dt, J 
= 3.5, 1.8 Hz, 1H), 4.26 (d, J = 3.9 Hz, 2H), 4.20 (dt, J = 8.6, 4.1 Hz, 1H, H-5), 2.10 (s, 6H), 
1.31 (s, 9H). 13C NMR (126 MHz; CDCl3) δ 170.9, 170.3, 152.1, 131.6, 129.4, 125.41, 125.31, 
119.1, 86.8, 84.0, 69.9, 64.8, 64.5, 63.1, 34.8, 21.02, 20.83. HRMS calculated for C22H27O5 
[M+H]+: 371.1780, Found: 371.1781. The characterization data is consistent with the literature.7 
58c was obtained using general procedure B in 70% isolated yield (244 
mg) as a pale yellow oil. (Elution: ethyl acetate/hexanes = 1/5); α:β = 
                                                          
6 S. Tanaka, T. Tsukiyama, M. Isobe, Tetrahedron Lett., 1993, 34, 5757.   
7 A. R. Yeager, G. K. Min, J. A. Porco, S. E. Schaus, Org. Lett., 2006, 8, 5065.  
36 
 
>99:1. 1H NMR (400 MHz; CDCl3): δ 7.44 (t, J = 1.8 Hz, 1H), 7.34-7.31 (m, 2H), 7.27 (m, 1H), 
5.97 (ddd, J = 10.2, 3.5, 1.9 Hz, 1H), 5.84 (dt, J = 10.2, 1.9 Hz, 1H), 5.34 (dq, J = 8.9, 2.0 Hz, 
1H), 5.19 (dt, J = 3.6, 1.8 Hz, 1H), 4.27 (d, J = 3.9 Hz, 2H), 4.17 (dt, J = 8.6, 4.2 Hz, 1H, H-5), 
2.11 (s, 6H). 13C NMR (126 MHz; CDCl3) δ 170.7, 170.2, 134.1, 131.6, 129.8, 129.5, 129.0, 
128.7, 125.7, 123.8, 85.9, 85.1, 70.1, 64.6, 64.2, 62.9, 20.93, 20.73. HRMS calculated for 
C18H17ClO5 [M+H]+: 349.0765, Found: 349.0771. 
58d was obtained using general procedure B in 73% isolated yield 
(243 mg) as a colorless semi-solid. (Elution: ethyl acetate/hexanes 
= 1/5); α:β = >99:1. 1H NMR (400 MHz; CDCl3): δ 7.46-7.41 (m, 
2H), 7.05-7.00 (m, 2H), 5.97 (ddd, J = 10.2, 3.5, 1.9 Hz, 1H), 5.83 (dt, J = 10.2, 1.9 Hz, 1H), 
5.34 (dq, J = 8.9, 2.0 Hz, 1H), 5.19 (dt, J = 3.6, 1.8 Hz, 1H), 4.27 (d, J = 3.9 Hz, 2H), 4.18 (dt, J 
= 8.6, 4.2 Hz, 1H, H-5), 2.10 (s, 6H). 13C NMR (126 MHz; CDCl3) δ 170.8, 170.2, 162.7 (JC-F = 
249 Hz), 133.75 (JC-F = 4.12 Hz), 129.0, 125.5, 118.20 (JC-F = 3.37 Hz), 115.60 (JC-F = 21.87 
Hz), 85.5, 84.40 (JC-F = 1.37 Hz), 70.0, 64.7, 64.3, 63.0, 20.97, 20.77. HRMS calculated for 
C18H18FO5 [M+H]+: 333.1060, Found: 333.1067. The characterization data is consistent with the 
literature.8 
58e was obtained using general procedure B in 68% isolated yield 
(267 mg) as a colorless semi-solid. (Elution: ethyl acetate/hexanes 
= 1/5); α:β = 98:2. 1H NMR (500 MHz; CDCl3): δ 7.46 (d, J = 
8.6 Hz, 2H), 7.31 (d, J = 8.6 Hz, 2H), 5.97 (ddd, J = 10.2, 3.5, 1.9 Hz, 1H), 5.84 (dt, J = 10.2, 2.0 
Hz, 1H), 5.34 (dq, J = 8.9, 2.0 Hz, 1H), 5.19 (dt, J = 3.6, 1.9 Hz, 1H), 4.27 (d, J = 4.4 Hz, 2H), 
4.17 (dt, J = 8.7, 4.2 Hz, 1H, H-5), 2.10 (s, 6H). 13C NMR (126 MHz; CDCl3) δ 170.7, 170.2, 
                                                          
8 A. K. Kusunuru, M. Tatina, S. K. Yousuf, D. Mukherjee, Chem. Commun., 2013, 49, 10154. 
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133.2, 131.5, 128.8, 125.6, 123.0, 121.0, 85.8, 85.5, 70.0, 64.6, 64.3, 62.9, 20.93, 20.73 HRMS 
calculated for C18H18BrO5 [M+H]+: 394.0259, Found: 394.0265. The characterization data is 
consistent with the literature.7 
58f was obtained using general procedure B in 83% isolated 
yield (284 mg) as a colorless semi-solid. (Elution: ethyl 
acetate/hexanes = 1/5); α:β = 96:4. 1H NMR (500 MHz; 
CDCl3): δ 10.02 (s, 1H), 7.86-7.85 (m, 2H), 7.62-7.60 (m, 2H), 6.00 (ddd, J = 10.3, 3.1, 2.0 Hz, 
1H), 5.87 (m, 1H), 5.36 (m, 1H), 5.24 (m, 1H), 4.29-4.28 (m, 2H), 4.20 (m, 1H, H-5), 2.11 (s, 
6H). 13C NMR (126 MHz; CDCl3) δ 191.1, 170.5, 170.0, 135.6, 132.1, 130.3, 129.2, 128.3, 
125.7, 88.5, 85.4, 70.0, 64.4, 64.0, 62.7, 20.72, 20.53. HRMS calculated for C19H19O6 [M+H]+: 
343.1103, Found: 343.1105. 
58g was obtained using general procedure B in 83% isolated yield (213 
mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/5); α:β = 98:2. 
1H NMR (400 MHz; CDCl3): δ 7.47-7.45 (m, 2H), 7.32 (m, 3H), 5.96 (d, 
J = 10.0 Hz, 1H), 5.80 (d, J = 10.1 Hz, 1H), 5.13 (m, 1H), 5.08 (d, J = 8.1 Hz, 1H), 4.08 (quintet, 
J = 6.5 Hz, 1H, H-5), 2.10 (s, 3H), 1.29 (d, J = 6.1 Hz, 3H). 13C NMR (126 MHz; CDCl3) δ 
170.5, 131.8, 128.2, 125.6, 124.8, 122.3, 102.1, 86.0, 85.5, 70.3, 68.2, 63.8, 21.1, 18.1. HRMS 
calculated for C16H17O3 [M+H]+: 257.1099, Found: 257.1102. The characterization data is 
consistent with the literature.9 
58h was obtained using general procedure B in 80% isolated yield 
(220 mg) as a yellow oil. (Elution: ethyl acetate/hexanes = 1/5); 
                                                          
9 J. S. Yadav, B. V. S. Reddy, C. V. Rao, M. Sridhar Reddy, Synthesis, 2003, 2, 2047. 
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α:β = 99:1. 1H NMR (400 MHz; CDCl3): δ 7.45-7.42 (m, 2H), 7.03-6.99 (m, 2H), 5.96-5.93 (m, 
1H), 5.80 (dt, J = 10.1, 2.0 Hz, 1H), 5.12 (dt, J = 3.5, 1.8 Hz, 1H), 5.07 (dq, J = 8.2, 2.0 Hz, 1H), 
4.06 (dq, J = 8.1, 6.3 Hz, 1H, H-5), 2.10 (s, 3H), 1.29 (d, J = 6.3 Hz, 3H). 13C NMR (126 MHz; 
CDCl3) δ 170.5, 162.6 (JC-F = 248.5 Hz), 133.87 (JC-F = 0.87 Hz), 129.2, 125.7, 118.43 (JC-F = 
3.5 Hz), 115.55 (JC-F = 22 Hz), 85.2, 84.9, 70.2, 68.2, 63.7, 21.1, 18.1. HRMS calculated for 
C16H16FO3 [M+H]+: 275.1005, Found: 275.1010. 
58i was obtained using general procedure B in 70% isolated yield 
(311 mg) as a colorless oil. (Elution: ethyl acetate/hexanes = 1/5); 
α:β = 95:5. 1H NMR (400 MHz; CDCl3): δ 7.34-7.26 (m, 14H), 
6.00 (dt, J = 10.2, 1.8 Hz, 1H), 5.87 (ddd, J = 10.2, 3.5, 1.8 Hz, 1H), 5.16 (m, 1H), 4.64-4.53 (m, 
4H), 4.20 (dq, J = 8.9, 1.9 Hz, 1H), 4.03 (dt, J = 8.9, 3.1 Hz, 1H, H-5), 3.77 (d, J = 3.2 Hz, 2H). 
13C NMR (126 MHz; CDCl3) δ 138.06, 137.88, 134.0, 131.7, 129.9, 129.4, 128.7, 128.38, 
128.31, 127.9, 127.6, 127.33, 127.25, 124.1, 93.9, 87.0, 84.6, 73.4, 72.4, 71.4, 69.8, 68.9, 64.4. 
HRMS calculated for C28H26ClO3 [M+H]+: 445.1492, Found: 445.1497. 
58j was obtained using general procedure B in 63% isolated yield 
(244 mg) as a colorless semi-solid. (Elution: ethyl acetate/hexanes = 
1/5); α:β = 99:1. 1H NMR (400 MHz; CDCl3): δ 7.46-7.43 (m, 2H), 
7.31 (m, 3H), 5.96 (m, J = 1.6 Hz, 1H), 5.83 (dq, J = 10.1, 1.8 Hz, 1H), 5.35-5.31 (m, 1H), 5.18 
(m, 1H), 4.06-4.01 (m, 1H, H-5), 3.86-3.79 (m, 2H), 2.08 (s, 3H), 0.90 (s, 9H), 0.09 (m, 3H), 
0.07 (m, 3H). 13C NMR (126 MHz; CDCl3) δ 170.3, 131.8, 129.3, 128.5, 128.2, 125.7, 122.4, 
86.2, 85.3, 72.8, 65.1, 64.2, 63.1, 60.4, 25.98, 25.82, 21.1, 18.4, 14.2. HRMS calculated for 
C22H31O4Si [M+H]+: 387.1913, Found: 387.1915. 
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58k was obtained using general procedure B in 66% isolated yield 
(278 mg) as a colorless semi-solid (Elution: ethyl acetate/hexanes 
= 1/5); α:β = 95:5. 1H NMR (500 MHz; CDCl3): δ 7.43 (t, J = 1.7 
Hz, 1H), 7.31 (m, J = 1.5 Hz, 2H), 7.24 (m, 1H), 5.94 (ddd, J = 10.1, 3.5, 1.8 Hz, 1H), 5.84 (dt, J 
= 10.1, 1.9 Hz, 1H), 5.32 (dq, J = 8.7, 2.0 Hz, 1H), 5.17 (dt, J = 3.5, 1.8 Hz, 1H), 4.00 (ddd, J = 
8.4, 5.5, 2.7 Hz, 1H, H-5), 3.85-3.76 (m, 2H), 2.09 (s, 3H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 
3H). 13C NMR (126 MHz; CDCl3) δ 170.3, 134.1, 131.7, 129.9, 129.5, 128.93, 128.84, 126.0, 
124.1, 86.7, 84.8, 73.0, 65.0, 64.1, 63.0, 25.9, 21.1, 18.4, -0.0, -5.3. HRMS calculated for 
C22H30ClO4Si [M+H]+: 421.1524, Found: 421.1530. 
58l was obtained using general procedure B in 70% isolated 
yield (283 mg) as a colorless semi-solid (Elution: ethyl 
acetate/hexanes = 1/5); α:β = 96:4. 1H NMR (500 MHz; 
CDCl3): δ 10.01 (s, 1H), 8.07 (d, J = 8.2 Hz, 2H), 7.82-7.81 (m, 2H), 7.55 (m, 3H), 7.42 (m, 2H), 
6.00 (ddd, J = 10.2, 3.5, 1.8 Hz, 1H), 5.90 (dt, J = 10.2, 1.9 Hz, 1H), 5.45 (dq, J = 6.9, 2.1 Hz, 
1H), 5.25 (m, 1H), 4.60 (dd, J = 12.0, 2.6 Hz, 1H), 4.46 (dd, J = 12.0, 5.9 Hz, 1H), 4.34 (ddd, J = 
8.8, 6.0, 2.7 Hz, 1H, H-5), 2.10 (s, 3H). 13C NMR (126 MHz; CDCl3) δ 191.3, 170.3, 166.3, 
135.7, 133.1, 132.2, 129.7, 129.4, 128.5, 128.3, 126.1, 88.8, 85.5, 70.5, 65.0, 64.3, 63.5, 21.0. 
HRMS calculated for C24H21O6 [M+H]+: 405.1260, Found: 405.1263. 
58m was obtained using general procedure B in 64% 1H 
NMR yield (314 mg) as a colorless semi-solid (~10% 
impurity noted). (Elution: ethyl acetate/hexanes = 1/5); α:β 
= 95:5. 1H NMR (500 MHz; CDCl3): δ 7.24-7.20 (m, 3H), 
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5.99-5.96 (m, 1H), 5.82 (dt, J = 10.2, 1.9 Hz, 1H), 5.34 (dq, J = 9.0, 2.0 Hz, 1H), 5.19 (dt, J = 
3.6, 1.8 Hz, 1H), 4.26 (d, J = 3.9 Hz, 2H), 4.21-4.17 (m, 1H, H-5), 2.89 (m, 2H), 2.51 (dd, J = 
18.9, 8.6 Hz, 1H), 2.42-2.38 (m, 1H), 2.29 (m, 1H), 2.14-2.01 (m, 11H), 1.63-1.44 (m, 6H), 0.91 
(s, 3H). 13C NMR (126 MHz; CDCl3) δ 220.5, 170.8, 170.2, 140.7, 136.6, 132.2, 129.27, 129.08, 
125.32, 125.31, 119.4, 86.7, 84.0, 69.9, 64.8, 64.4, 63.0, 50.4, 47.8, 44.4, 37.9, 35.7, 31.5, 29.0, 
26.2, 25.5, 21.5, 20.97, 20.78, 13.8. HRMS calculated for C30H35O6 [M+H]+: 491.2355, Found: 
491.2361. 
 
2.4 Conclusions 
To summarize, an efficient TA-Au catalyzed hydroalkynylation of vinyl ethers has been 
developed and extended to the alkynylation-Ferrier reaction of glycal derivatives. This reaction 
demonstrates the disparate reactivity of vinyl ethers in comparison with alkenes towards terminal 
alkynes in the presence of catalytic gold.  
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CHAPTER 3 
ALKYNOL CYCLOISOMERIZATION-ALKYNYLATION TANDEM REACTION  
 
3.1 Introduction 
Some passages and figures in this chapter have been quoted from the following source: 
Smith, C. A.; Motika, S. E.; Wojtas, L.; Shi, X. Chem. Commun. 2017, 53, 2315. 
As an extension of our Au(I) catalyzed vinyl ether alkynylation reaction,1 we reasoned 
whether a tandem reaction was plausible wherein the vinyl ether could be generated in-situ via 
Au(I)-catalyzed cycloisomerization of a homo-propargyl alcohol. Although gold has proven 
effective in activating unsaturated C-C functional groups (alkyne, allene, and alkene; Figure 3.1) 
via its π-acidic nature, issues in selectivity arise when multiple reactive functional groups are 
present.2 Additional issues in selectively achieving intra- and inter- molecular reactivity may also 
arise.3 Thus, the design of a selective Au(I)-catalytic system involving both a homo-propargyl 
alcohol and terminal alkyne is a considerable issue due to these considerations.  
 
 
Figure 3.1. Selectivity issues arising from Au’s π-acidity. 
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Previously, our group has demonstrated the TA-Au catalyzed intermolecular condensation 
of homo-propargyl alcohols and terminal aliphatic alkynes to furnish 2,3-dihydrooxepines. The 
proposed reaction pathway involves an initial intermolecular alkoxylation to form a reactive 
vinyl ether intermediate that subsequently undergoes an enyne cycloisomerization to form 2,3-
dihydrooxepines.4 Although this reaction tolerated a variety of terminal aliphatic alkynes, 
subjecting aromatic alkynes to the reaction conditions resulted in messy reaction mixtures.  
This difference in reactivity is unexpected when considering the abundance of gold-
catalyzed reactions involving π-acid activation of aromatic terminal alkynes.5 Furthermore, for 
the TA-Au catalyzed alkynylation of vinyl ether 4, aliphatic alkynes such as 1-hexyne furnished 
slightly lower yields of the desired product in comparison with aromatic alkynes. Thus, using 
these previous results as an impetus, we sought to: 1) extend the reaction scope of the 2,3-
dihydrooxepine synthesis to encompass aryl-substituted terminal alkynes and, 2) develop a 
cascade reaction for the alkynylation of vinyl ether 61 (Figure 3.2).6‒7 
 
 
Figure 3.2. Proposed goals of homopropargyl alcohol gold-catalytic study. 
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3.2 Results and Discussion 
3.2.1 Screening of Catalytic Conditions 
The reaction of 47a with aromatic alkyne 62b under our reported conditions for aliphatic 
terminal alkynes resulted in an un-characterized mixture of products, with no formation of 
dihydrooxepine 60a (entry 2, Table 3.1). To identify a catalytic condition for the cascade 
reaction, we screened various gold catalysts. For comprehensive screening conditions, see Table 
3.5. The hydroalkynylation product 61b was observed in low yield when 5% RuPhosAuNTf2 
was used as the catalyst (entry 3, Table 3.1). Increasing the temperature to promote gold pi-acid 
activation of the internal alkyne increased the yield to 61% (entry 4, Table 3.1). Altering the 
primary ligand to an electron-rich N-heterocyclic carbene, IPr, further increased the yield to 91% 
(entry 5, Table 3.1). Lowering the catalyst loading to 4 mol % did not appreciably decrease the 
yield (87% yield, entry 6, Table 3.1).  
 
Table 3.1. Screening of catalytic conditions for formation of 60 and 61. 
 
Entry Conditions 2 (eq) 
convn 
(%) 
yield (%) 
60 61 
1 
5% [XPhosAu(TA)]OTf, 1% Cu(OTf)2, 
toluene, rt, 24h 
62a (3) 100 84% n.d. 
2 
Same conditions as entry 1, 
messy reaction 
62b (3) 100 <5% n.d. 
3 5% RuPhosAuNTf2, CHCl3, rt, 12h 62b (3) 100 n.d. 47% 
4 5% RuPhosAuNTf2, CHCl3, 40 
oC, 4h 62b (3) 100 n.d. 61% 
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Table 3.1. (Continued) Screening of catalytic conditions for formation of 60 and 61. 
5 5% IPrAuNTf2, CHCl3, 40 
oC, 4h 62b (3) 100 n.d. 91% 
6 4% IPrAuNTf2, CHCl3, 40 
oC, 4h 62b (3) 100 n.d. 87% 
7 1% IPrAuNTf2, CHCl3, 40 
oC, 4h 62b (3) 100 n.d. 34% 
8 5% IPrAuNTf2, CHCl3, 40 
oC, 4h 62b (2) 100 56% 36% 
9 
Other catalysts (5) including AuCl3, 
HOTf, pTsOH•H2O, In(OTf)3, Pd(OAc)2, 
CuBr, Cu(OTf)2, ZnBr2, AgOTf 
62b (3) <30% n.d. <5% 
 
a General conditions: 47a (0.2 mmol), 62 (eq), and gold catalyst (mol %) in CHCl3 (0.8 mL) under Ar; b The yield was 
determined by 1H-NMR using 1,3,5-trimethoxybenzene as the internal standard. 
 
3.2.2 Substrate Scope 
Phenylacetylene derivatives bearing various substituents with electron-deficient (61d – 
61g; 61h, 61i) and electron-rich (61c, 61j, 61l) nature were tolerated in the reaction (Table 3.2). 
The scope was also extended to ferrocenyl, thiophenyl, and pyrenyl aromatic alkynes (61m – 
61o). The structure of the ferrocenyl derivative was confirmed by X-ray-crystallography. 
Furthermore, phenylacetylene derivatives with adamantyl, indole, and benzofuran functional 
groups at the para-position also afforded the desired products (61p, 61s, 61t). Illustrating the 
functional group tolerance of the reaction conditions, the amino acid derivative 61q and estrone 
derivative 61r also conferred the alkynylated products in moderate yield. However, terminal 
alkynes that were not aromatic, bearing substituents such as -nBu, -TMS, and -cyclopentyl, were 
not able to furnish the desired product.  
Altering phenyl substitution on the homo-propargyl alcohol with para (61aa – 61ae), 
meta- (61af – 61ah), and ortho- (61ai) functionalities afforded the respective products in good 
yields (Table 3.3). Alternatively, the alkyne may be substituted with a naphthyl group (61aj). 
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Table 3.2. Acetylene substrate scope of tandem cycloisomerization-hydroalkynylation. 
 
 
When the alkyl chain of the homo-propargyl alcohol was extended, aliphatic substitution 
selectively yielded the 5-exo product 61ak, while phenyl substitution afforded a 10:3 mixture of 
exo:endo isomers (61al). Terminal alkynes could also be used to yield the 5-exo (61am), 6-exo 
(61an), and 7-exo (61ao) alkynylated products. However, the 8-exo product was not able to be 
formed via the corresponding terminal alkynol. Lastly, the diastereoselectivity of the reaction is 
modest, as alpha-methyl homo-propargyl alcohol yielded a dr of 3:2 (61aq) and an α,β di-
substituted homo-propargyl alcohol did not exhibit diastereoselectivity (61ap).   
 
 
49 
 
3.2.3 Ring-Expansion Cascade 
If two equivalents of terminal alkyne are used, the yield of the desired 62b is lessened 
with concurrent formation of the dihydrooxepine 60b. Further reducing the equivalents of 
phenylacetylene to 1.1 equiv. afforded the dihydrooxepine in 74% yield. 
 
Table 3.3. Alkynol substrate scope of tandem cycloisomerization-hydroalkynylation. 
 
 
However, due to the instability of 60b to chromatographic separation, a Diels alder 
cycloaddition utilizing tetracyanoethylene was performed to form stable cycloadducts.8 X-ray 
crystallography was used to characterize the structure of 64b (Figure 3.3). Using these optimized 
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conditions, a variety of aromatic alkynes afforded moderate yields of the corresponding oxepine 
cycloadducts (Table 3.4). 
 
 
Figure 3.3. X-ray crystal structure of 64b. 
 
Table 3.4. Substrate scope of ring-opening cascade. 
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3.2.4 Mechanistic Investigations 
The kinetics of the ring-expansion cascade were monitored with 1H-NMR. Within 15 
minutes, homo-propargyl 47a was converted to the corresponding hydrolysis product, 
presumably via a gold-catalyzed process (Figure 3.4).9  
 
 
Figure 3.4. Reaction kinetic profile of ring-opening cascade. 
 
Based on this result, it is apparent that 61b is an intermediate for the formation of 60b. 
Following the complete conversion of the ketone to the hydroalkynylated product, a 
comparatively slow formation of the oxepine occurs from the alkynyl ether. Conversely, when 
the equivalents of phenylacetylene is increased to 3 equiv., the yield of 60b is low even after an 
extended reaction time of 48 hrs. To provide further evidence that the oxepine 60b arises via 
rearrangement of alkynylether, 61b was isolated and used in the optimized reaction conditions. 
47a 
 
62b 
 
61b 
 
 
60b 
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After approximately 6 hours, 61b was absent and the oxepine 60b was formed in 63% 1H-NMR 
yield (Figure 3.3). However, subjecting 61b to catalytic HNTf2 led solely to decomposition with 
no formation of the corresponding oxepine (Figure 3.4). These results constitute evidence that 
the ring-expansion arises from a gold-catalyzed rearrangement of 61b.10 
 
 
Figure 3.5. Mechanistic investigation of homo-propargyl alcohol reaction. 
 
Additionally, the lack of formation of alkynylated product when utilizing aliphatic 
terminal alkynes was investigated by performing a series of reactions (Figure 3.5). Reacting 
alkyne 47a or ketone 65a with equimolar phenylacetylene and 1-hexyne afforded only the 
alkynylation product incorporating phenylacetylene. This suggests that aliphatic and aromatic 
substitution on the gold acetylide affects its reactivity. One possible explanation of this disparate 
reactivity it that the intramolecular cyclization of 47a in the presence of phenylacetylene is 
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sufficiently faster than the intermolecular hydroalkoxylation of the terminal alkyne. Thus, by 
employing the N-heterocyclic carbene gold catalyst IPrAuNTf2,11 a catalytic system was 
demonstrated that is amenable to the formation of both arylethynylethers and 2,3-
didhydrooxepines.  
 
3.3 Experimental Section 
Unless otherwise noted, all reagents and solvents were obtained from a commercial 
provider and used without further purification. All reactions were run in flame-dried glassware 
under an atmosphere of nitrogen. Chloroform was dried over 3Å MS prior to use. 1H- and 13C-
NMR data was recorded on an Agilent 400 or 500 MHz NMR spectrometer. Reaction monitoring 
was carried out using either 1H-NMR or analytical thin-layer chromatography. Analytical thin-
layer chromatography was performed with pre-coated, glass-baked plates (250µ) and visualized 
by fluorescence or charring with potassium permanganate stain. Flash column chromatography 
was performed on 230-430 mesh silica gel. Chemical shifts for starting materials and products 
were recorded relative to internal TMS (0.00 ppm) for 1H-NMR and CDCl3 (77.00 ppm) for 13C-
NMR data. High-resolution mass spectra were recorded on a LTQ-FTUHRA spectrometer. 
 
Table 3.5 Comprehensive screening table of tandem reaction 
 
Entry Conditions T °C t (h) eq 2 
convn 
(%) 
yield (%)a 
60b 61b 65a 
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Table 3.5. (Continued) Comprehensive screening table of tandem reaction 
 
Entry Conditions T °C t (h) eq 2 
convn 
(%) 
yield (%)a 
60b 61b 65a 
1 
5% [XPhosAu(TA)]OTf,  
1% Cu(OTf)2, PhCH3 
rt 24h 3 100 >5% n.d. n.d. 
2 5% RuPhosAuNTf2 rt 12h 3 100 n.d. 47 n.d. 
3 5% RuPhosAuNTf2 40 4h 3 100 n.d. 61 n.d. 
4 5% IPrAuNTf2 40 4h 3 100 n.d. 91 n.d. 
5 5% IPrAuNTf2 40 4h 2 100 56 36 n.d. 
6 5% IPrAuNTTf2 40 11h 1.1 100 74 n.d. n.d. 
7 4% IPrAuNTf2 40 4h 3 100 n.d. 87 n.d. 
8 1% IPrAuNTf2 40 4h 3 100 n.d. 34 53 
9 5% PPh3AuCl/AgOTf 40 4h 3 100 n.d. 32 61 
10 5% PPh3AuCl 40 4h 3 44 n.d. n.d. 44 
11 5% PPh3AuNTf2 40 4h 3 100 n.d. 28 64 
12 5% (tBu)3PAuNTf2 40 4h 3 100 n.d. 32 60 
13 5(OAr)3PAuNTf2b 40 4h 3 100 n.d. 32 58 
14 5% JohnPhosAuNTf2 40 4h 3 100 n.d. 27 66 
15 5% XPhosAuNTf2 40 4h 3 100 n.d. 22 69 
16 5% [RuPhosAu(TA-H)]OTf 40 4h 3 100 n.d. 29 47 
17 5% [RuPhosAu(TA-Me)]OTf 40 4h 3 100 n.d. 37 32 
18 5% AuCl3 40 4h 3 100 n.d. n.d. n.d. 
19 10% AgSbF6 40 4h 3 46 n.d. n.d. 23 
20 10% AgOTf 40 4h 3 16 n.d. n.d. 16 
21 10% In(OTf)3 40 4h 3 100 n.d. <5% n.d. 
22 10% HOTf 40 4h 3 100 n.d. n.d. 15 
23 10% ZnBr2 40 4h 3 45 n.d. n.d. 38 
24 5% CuBr 40 4h 3 0 n.d. <5% n.d. 
25 5% CuI 40 4h 3 0 n.d. <5% n.d. 
26 5% Cu(OTf)2 40 4h 3 0 n.d. <5% n.d. 
27 5% Pd(OAc)2 40 4h 3 0 n.d. <5% n.d. 
 
a The yield was determined by 1H-NMR using 1,3,5-trimethoxybenzene as the internal standard. b Ar = 2,4-Di-
tButylBenzene 
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3.3.1 General Coupling Procedure for Synthesizing Compounds 47a-47j, 47l 
 
Aryl-substituted homopropargyl alcohols (47a-47j; 47l) were synthesized according to a 
modified literature procedure.10 To a flame-dried flask was added aryl-iodide (1.0 eq, 4 mmol), 
alkynol (1.2 eq, 4.8 mmol), and triethylamine (0.25M). The mixture was placed under inert 
atmosphere and Pd(PPh3)2Cl2 (2 mol %, 0.08 mmol) then CuI (1 mol %, 0.04 mmol) were 
sequentially added. The reaction was heated to 60 °C and stirred for 2-12 h, monitoring by TLC 
until completion. The crude was filtered through a short pad of silica, eluting with EtOAc (2 x 50 
mL), then concentrated in vacuo. The mixture was purified via flash column chromatography on 
silica gel (eluting with 3:1 hexanes/ethyl acetate) to afford the corresponding aryl-substituted 
alkynols.  
The title compound 47i was isolated via flash chromatography on silica gel 
(Elution: hexanes/ethyl acetate = 3/1) as a pale-yellow oil (621 mg, 86% 
yield). 1H NMR (500 MHz; CDCl3): δ 7.45 – 7.34 (m, 1H), 7.28 – 7.12 (m, 
3H), 3.83 – 3.73 (m, 2H), 3.01 (s, 1H), 2.68 – 2.60 (m, 2H). 13C NMR (126 MHz; CDCl3): δ 
133.97, 131.52, 129.76, 129.45, 128.14, 125.11, 88.09, 80.88, 60.93, 23.63. HRMS calculated 
for C10H10ClO [M+H]+: 181.0420, Found: 181.0402. 
 
 
                                                          
10 D. Y. Li, H. J. Chen, and P. N. Liu, Agnew. Chem. 2016, 128, 381.   
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3.3.2 General Procedure for Synthesizing Compounds 47p, 47q 
Chiral aryl-substituted homopropargyl alcohols (47p, 
47q) were synthesized according to literature 
procedure.11  
 
3.3.3 General EDC Coupling Procedure  
 
To an oven-dried flask was added the corresponding carboxylic acid (1.2 eq, 4.8 mmol) 
in DCM (0.5M). DMAP (1.2 eq, 4.8 mmol) then alcohol (1.0 eq, 4.0 mmol) were added 
sequentially. The mixture was cooled to 0 °C. After cooling, EDC•HCl (1.5 eq, 6.0 mmol) was 
added slowly and the reaction was stirred at 0 °C for 5 minutes. The mixture was warmed to 
room temperature and stirred until completion, monitoring by TLC. The reaction was then 
diluted with water (20 mL), extracted with DCM (3 x 15 mL), and washed with brine (5 mL). 
The mixture was purified via flash column chromatography on silica gel (eluting with 5:1 
hexanes/ethyl acetate) to afford the corresponding alkynes.   
The title compound 47p was isolated via flash chromatography on silica gel 
(Elution: hexanes/ethyl acetate = 5/1) as a white solid (754 mg, 64% yield). 1H 
NMR (400 MHz; CDCl3): δ 7.55 – 7.39 (m, 2H), 7.30 – 7.21 (m, 2H), 5.07 (s, 
                                                          
2 R. D. Grigg, J. W. Rigoli, S. D. Pearce, and J. M. Schomaker, Org. Lett. 2012, 14, 280. 
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2H), 3.05 (s, 1H), 2.05 – 1.54 (m, 15H). 13C NMR (126 MHz; CDCl3): δ 177.31, 137.29, 132.23, 
127.47, 121.67, 83.31, 77.44, 65.17, 40.76, 38.80, 36.45, 27.89. HRMS calculated for C20H23O2 
[M+H]+: 295.1698, Found: 295.1674. 
The title compound 47q was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 5/1) as a white solid 
(716 mg, 54% yield). 1H NMR (400 MHz; CDCl3): δ 7.40 (d, J = 
8.0 Hz, 2H), 7.24 (d, J = 8.0 Hz, 1.4H), 7.16 (d, J = 8.2 Hz, 0.6H), 5.16 – 4.97 (m, 3H), 4.25 – 
4.16 (m, 1H), 3.05 (s, 1H), 2.24 – 1.96 (m, 1H), 1.37 (s, 9H), 0.87 (d, J = 6.8 Hz, 3H), 0.79 (d, J 
= 6.8 Hz, 3H). 13C NMR (126 MHz; CDCl3): δ 172.14, 155.61, 136.11, 134.47, 132.22, 131.65, 
129.95, 128.06, 122.35, 122.13, 83.13, 79.68, 77.86, 66.17, 58.55, 31.16, 28.26, 18.99, 17.50. 
HRMS calculated for C19H26NO4 [M+H]+: 332.1862, Found: 332.1846. 
The title compound 47s was isolated via flash chromatography 
on silica gel (Elution: hexanes/ethyl acetate = 5/1) as a white 
solid (906 mg, 82% yield). 1H NMR (400 MHz; CDCl3): δ 7.66 
(d, J = 7.8 Hz, 1H), 7.59 – 7.47 (m, 4H), 7.47 – 7.36 (m, 3H), 7.29 (t, J = 7.5 Hz, 1H), 5.39 (s, 
2H), 3.08 (s, 1H). 13C NMR (126 MHz; CDCl3): δ 159.28, 155.81, 145.13, 136.04, 132.39, 
128.20, 127.79, 126.86, 123.85, 122.86, 122.30, 114.39, 112.39, 83.17, 77.77, 66.42. HRMS 
calculated for C18H12NaO3 [M+Na]+: 299.0684, Found: 299.0670. 
The title compound 47t was isolated via flash chromatography 
on silica gel (Elution: hexanes/ethyl acetate = 5/1) as a white 
solid (706 mg, 61% yield). 1H NMR (500 MHz; CDCl3): δ 7.69 
– 7.62 (m, J = 8.0 Hz, 1H), 7.50 (d, J = 8.2 Hz, 2H), 7.43 – 7.33 (m, 5H), 7.17 – 7.10 (m, 1H), 
5.34 (s, 2H), 4.07 (s, 3H), 3.08 (s, 1H). 13C NMR (126 MHz; CDCl3): δ 161.83, 139.78, 136.82, 
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132.35, 127.80, 127.32, 125.81, 125.19, 122.63, 121.99, 120.64, 110.64, 110.25, 83.265, 77.61, 
65.56, 31.63. HRMS calculated for C19H16NO2 [M+H]+: 290.1181, Found: 290.1168. 
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To a 2 mL vial charged with IPrAuNTf2 (6.9 mg, 0.008 mmol) was sequentially added 
CHCl3 (0.8 mL), 47 (1.0 eq, 0.2 mmol), and 62 (3.0 eq, 0.6 mmol). The reaction mixture was 
purged with argon for at least 1 minute and then stirred at 40 °C. After the reaction is complete 
(0.25h-7h), the mixture was directly purified via flash column chromatography on silica gel or by 
preparatory TLC to afford the desired product.  
61b was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 24h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 20/1) as a yellow oil (43 mg, 
87%). 1H NMR (500 MHz, CDCl3): δ 7.70 – 7.63 (m, 2H), 7.50 – 7.44 (m, 2H), 7.40 – 7.33 (m, 
2H), 7.32 – 7.27 (m, 4H), 4.32 – 4.10 (m, 2H), 2.62 (ddd, J = 12.2, 7.6, 4.7 Hz, 1H), 2.36 – 2.24 
(m, 1H), 2.19 (dt, J = 12.0, 8.0 Hz, 1H), 2.13 – 2.02 (m, 1H). 13C NMR (126 MHz; CDCl3): 
143.64, 131.74, 128.25, 128.22, 128.18, 127.49, 125.32, 122.87, 91.26, 84.98, 80.92, 68.47, 
43.02, 25.87. HRMS calculated for C18H17O [M+H]+: 249.1279, Found: 249.1278. 
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61c was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 
°C, 4h, in CHCl3. The title compound was isolated via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 20/1) 
as a pale-yellow oil (40 mg, 72%). 1H NMR (500 MHz; CDCl3): δ 
7.64 (d, J = 7.8 Hz, 2H), 7.48 – 7.20 (m, 5H), 6.82 (d, J = 8.8 Hz, 2H), 4.20 (m, 2H), 3.81 (s, 
3H), 2.65 – 2.49 (m, 1H), 2.33 – 1.98 (m, 3H). 13C NMR (126 MHz; CDCl3): δ 159.53, 143.85, 
133.17, 128.18, 127.40, 125.33, 114.98, 113.78, 89.81, 84.86, 80.95, 68.40, 55.26, 43.02, 25.86. 
HRMS calculated for C19H19O2 [M+H]+: 279.1385, Found: 279.1390. 
61d was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
4h, in CHCl3. The title compound was isolated via preparatory TLC 
(Elution: hexanes/ethyl acetate = 20/1) as a yellow oil (54 mg, 86%). 
1H NMR: (500 MHz; CDCl3): δ 7.67 – 7.60 (m, 2H), 7.58 – 7.52 (m, 
4H), 7.38 (m, 2H), 7.36 – 7.28 (m, 1H), 4.22 (m, 2H), 2.62 (m, 1H), 2.32 – 2.18 (m, 2H), 2.12 – 
2.04 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 143.26, 131.97, 130.00 (q, JC-F = 32.58 Hz), 
128.31, 127.64, 126.66, 125.19, 125.15, 122.79, 93.88, 83.54, 80.79, 68.62, 42.87, 25.86. HRMS 
calculated for C19H16F3O [M+H]+: 317.1153, Found: 317.1149. 
61e was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
4h, in CHCl3. The title compound was isolated via flash chromatography 
on silica gel (Elution: hexanes/ethyl acetate = 20/1) as a yellow oil (44 
mg, 82%). 1H NMR: (500 MHz; CDCl3): δ 7.67 – 7.60 (m, 2H), 7.47 – 
7.40 (m, 2H), 7.37 (t, J = 7.6 Hz, 2H), 7.30 (t, J = 7.3 Hz, 1H), 7.03 – 6.95 (m, 2H), 4.25 – 4.15 
(m, 2H), 2.60 (m, 1H), 2.31 – 2.13 (m, 2H), 2.11 – 2.01 (m, 1H). 13C NMR: (126 MHz; CDCl3): 
δ 162.29 (d, JC-F = 249.33 Hz), 143.59, 133.63 (d, JC-F = 8.35 Hz), 128.24, 127.52, 125.25, 
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118.92 (d, JC-F = 3.14 Hz), 115.45 (d, JC-F = 22.04 Hz), 91.00, 83.85, 80.84, 68.50, 42.94, 25.86. 
HRMS calculated for C18H16FO [M+H]+: 267.1185, Found: 267.1180. 
61f was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
4h, in CHCl3. The title compound was isolated via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 30/1) as 
a yellow oil (44 mg, 68%). 1H NMR (400 MHz; CDCl3): δ 7.63 – 7.52 
(m, 2H), 7.41 (d, J = 8.5 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.30 – 7.27 (m, 3H), 4.34 – 4.08 (m, 
2H), 2.62 – 2.53 (m, 1H), 2.29 – 2.14 (m, 2H), 2.09 – 2.01 (m, 1H). 13C NMR (101 MHz; 
CDCl3): δ 143.42, 133.16, 131.42, 128.24, 127.54, 125.20, 122.47, 121.79, 92.50, 83.82, 80.82, 
68.52, 42.85, 25.83. HRMS calculated for C18H16BrO [M+H]+: 327.0385, Found: 327.0371. 
61g was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
4h, in CHCl3. The title compound was isolated via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 20/1) as 
a colorless oil (39 mg, 61%). 1H NMR (500 MHz; CDCl3): δ 7.71 (s, 1H), 7.64 – 7.60 (m, 3H), 
7.55 (d, J = 7.9 Hz, 1H), 7.45 – 7.36 (m, 3H), 7.31 (m, 1H), 4.21 (m, 2H), 2.62 (ddd, J = 12.2, 
7.3, 4.7 Hz, 1H), 2.36 – 2.16 (m, 2H), 2.16 – 2.02 (m, 1H). 13C NMR (126 MHz; CDCl3) δ 
143.29, 134.83, 130.81 (q, JC-F = 32.75 Hz), 128.72, 128.54, 128.31, 127.63, 125.19, 124.82, 
123.77, 122.59, 93.01, 83.36, 80.77, 68.60, 42.86, 25.86. HRMS calculated for C19H16F3O 
[M+H]+: 317.1153, Found: 317.1155. 
61h was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 20/1) as a colorless oil (47 mg, 
89%). 1H NMR (400 MHz; CDCl3): δ 7.62 (d, J = 7.4 Hz, 2H), 7.37 (t, J = 7.5 Hz, 2H), 7.34 – 
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7.18 (m, 3H), 7.14 (d, J = 9.7 Hz, 1H), 7.07 – 6.95 (m, 1H), 4.32 – 4.10 (m, 2H), 2.66 – 2.54 (m, 
1H), 2.35 – 1.97 (m, 3H). 13C NMR (126 MHz; CDCl3): δ 163.24, 161.28, 143.38, 129.74 (d, JC-
F = 8.58 Hz), 128.27, 127.58, 125.23, 124.68 (d, JC-F = 9.66 Hz) 118.54 (d, JC-F = 22.82 Hz), 
115.60 (d, JC-F = 21.11 Hz), 92.28, 83.71, 80.80, 68.55, 42.91, 25.85. HRMS calculated for 
C18H16FO [M+H]+: 267.1185, Found: 267.1189. 
61i was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
1.5h, in CHCl3. The title compound was isolated via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 50/1) as 
a colorless oil (41 mg, 73%). 1H NMR (400 MHz; CDCl3): δ 7.62 (d, J = 7.7 Hz, 2H), 7.44 (s, 
1H), 7.40 – 7.15 (m, 6H), 4.41 – 4.02 (m, 2H), 2.73 – 2.43 (m, 1H), 2.48 – 1.92 (m, 3H). 13C 
NMR (101 MHz; CDCl3): δ 143.33, 133.99, 131.59, 129.82, 129.39, 128.51, 128.25, 127.56, 
125.20, 124.53, 92.57, 83.50, 80.78, 68.52, 42.88, 25.82. HRMS calculated for C18H16ClO 
[M+H]+: 283.0890, Found: 283.0889. 
61j was synthesized with 4 mol% IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 50/1) as a yellow oil (43 mg, 
82%). 1H NMR (500 MHz; CDCl3): δ 7.66 – 7.61 (m, 2H), 7.36 (t, J = 7.6 Hz, 2H), 7.28 (t, J = 
8.3 Hz, 1H), 7.18 (t, J = 7.6 Hz, 1H), 7.11 (d, J = 7.6 Hz, 1H), 4.27 – 4.13 (m, 2H), 2.59 (ddd, J 
= 12.2, 7.6, 4.6 Hz, 1H), 2.31 – 2.24 (m, 4H), 2.17 (m, 1H), 2.12 – 2.02 (m, 1H). 13C NMR (126 
MHz; CDCl3): δ 143.68, 137.85, 132.33, 129.12, 128.79, 128.20, 128.08, 127.46, 125.33, 
122.66, 90.87, 85.16, 80.93, 68.43, 43.03, 25.87, 21.18. HRMS calculated for C19H19O [M+H]+: 
263.1436, Found: 263.1434. 
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61k was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via preparatory TLC (Elution: 
hexanes/ethyl acetate = 20/1) as a colorless oil (37 mg, 58%). 1H NMR 
(500 MHz; CDCl3): δ 7.67 – 7.61 (m, 3H), 7.57 (d, J = 7.7 Hz, 1H), 7.46 (t, 
J = 7.5 Hz, 1H), 7.38 (m, 3H), 7.29 (m, 1H), 4.28 – 4.14 (m, 2H), 2.64 (ddd, J = 11.3, 7.6, 3.7 
Hz, 1H), 2.40 – 2.24 (m, 1H), 2.20 – 2.02 (m, 2H). 13C NMR (126 MHz; CDCl3): δ 143.00, 
133.96, 131.56 (q, JC-F = 30.36 Hz), 131.33, 128.24, 128.02, 127.59, 125.72 (q, JC-F = 4.97 Hz) , 
125.26, 124.65, 122.47, 121.14, 96.99, 81.00, 68.53, 42.94, 25.71. HRMS calculated for 
C19H16F3O [M+H]+: 317.1153, Found: 317.1148. 
61l was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 15m, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 50/1) as a pale-yellow oil (49 
mg, 94%). 1H NMR (500 MHz; CDCl3): δ 7.67 (d, J = 7.5 Hz, 2H), 7.42 (d, J = 7.6 Hz, 1H), 
7.38 (t, J = 7.6 Hz, 2H), 7.30 (t, J = 7.3 Hz, 1H), 7.23 – 7.17 (m, 2H), 7.15 – 7.09 (m, 1H), 4.29 
– 4.16 (m, 2H), 2.61 (ddd, J = 12.3, 7.8, 4.5 Hz, 1H), 2.44 (s, 3H), 2.39 – 2.25 (m, 1H), 2.24 – 
2.14 (m, 1H), 2.14 – 2.03 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 143.59, 140.23, 131.96, 
129.33, 128.27, 128.20, 127.48, 125.44, 125.34, 122.63, 95.21, 84.07, 81.12, 68.35, 43.16, 25.87, 
20.73. HRMS calculated for C19H19O [M+H]+: 263.1436, Found: 263.1434. 
61m was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 5h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 20/1) as an orange solid (59 mg, 
83%) and crystallized by slow evaporation of a DCM/Hexanes solution at 
room temperature. 1H NMR (500 MHz; CDCl3): δ 7.69 – 7.61 (m, 2H), 7.37 (t, J = 7.6 Hz, 2H), 
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7.29 (t, J = 7.3 Hz, 1H), 4.43 (t, J = 1.8 Hz, 2H), 4.27 – 4.13 (m, 9H), 2.55 (ddd, J = 12.1, 7.7, 
4.6 Hz, 1H), 2.33 – 2.22 (m, 1H), 2.20 – 2.10 (m, 1H), 2.10 – 2.02 (m, 1H). 13C NMR (126 
MHz; CDCl3): δ 143.91, 128.15, 127.40, 125.36, 87.40, 83.64, 81.11, 71.57, 71.43, 69.80, 68.57, 
68.26, 64.90, 43.04, 25.86. HRMS calculated for C22H21FeO [M+H]+: 357.0942, Found: 
357.0924. 
61n was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 20/1) as a yellow oil (47 mg, 
93%). 1H NMR (400 MHz; CDCl3): δ 7.68 – 7.56 (m, 2H), 7.47 – 7.43 (m, 1H), 7.36 (t, J = 7.5 
Hz, 2H), 7.30 – 7.23 (m, 2H), 7.11 (d, J = 5.0 Hz, 1H), 4.31 – 3.98 (m, 2H), 2.59 (ddd, J = 12.1, 
7.2, 4.8 Hz, 1H), 2.43 – 1.93 (m, 3H). 13C NMR (101 MHz; CDCl3): δ 143.62, 129.97, 128.77, 
128.19, 127.45, 125.27, 125.09, 121.85, 90.81, 80.89, 80.03, 68.44, 42.89, 25.83. HRMS 
calculated for C16H15OS [M+H]+: 255.0844, Found: 255.0840. 
61o was synthesized with 4 mol% IPrAuNTf2, 3 equiv. alkyne, 40 
°C, 4h, in CHCl3. The title compound was isolated via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 20/1) 
as a pale-yellow oil (42 mg, 56%). 1H NMR (400 MHz; CDCl3): δ 
8.49 (d, J = 9.1 Hz, 1H), 8.18 (t, J = 6.86, 2H), 8.14 – 7.97 (m, 7H), 7.82 – 7.74 (m, 1H), 7.42 (t, 
J = 7.6 Hz, 2H), 7.32 (t, J = 7.3 Hz, 1H), 4.38 (td, J = 8.1, 6.0 Hz, 1H), 4.29 – 4.24  (m, 1H), 
2.79 (ddd, J = 12.2, 7.5, 4.6 Hz, 1H), 2.53 – 2.35 (m, 1H), 2.35 – 2.25 (m, 1H), 2.25 – 2.08 (m, 
1H). 13C NMR (101 MHz; CDCl3): δ 143.69, 132.01, 131.20, 131.18, 130.99, 129.76, 128.32, 
128.08, 127.58, 127.19, 126.16, 125.53, 125.50, 125.41, 124.34, 124.24, 117.37, 96.97, 84.13, 
81.34, 68.57, 43.22, 26.02. HRMS calculated for C28H21O [M+H]+: 373.1592, Found: 373.1587. 
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61p was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
1.5h, in CHCl3. The title compound was isolated via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 15/1) as 
a colorless oil (58 mg, 66%). 1H NMR (500 MHz; CDCl3): δ 7.67 – 
7.60 (m, 2H), 7.44 (d, J = 8.2 Hz, 2H), 7.41 – 7.33 (m, 2H), 7.32 – 7.24 
(m, 3H), 5.07 (s, 2H), 4.29 – 4.10 (m, 2H), 2.60 (ddd, J = 12.2, 7.5, 4.7 
Hz, 1H), 2.28 (ddd, J = 11.7, 7.8, 6.1 Hz, 1H), 2.23 – 2.15 (m, 1H), 2.12 – 1.97 (m, 4H), 1.93 – 
1.86 (m, 6H), 1.75 – 1.67 (m, 6H). 13C NMR (101 MHz; CDCl3): δ 177.31, 143.56, 136.69, 
131.83, 128.21, 127.47, 125.28, 122.48, 91.59, 84.64, 80.89, 68.46, 65.25, 42.98, 40.75, 38.79, 
36.45, 27.89, 25.84. HRMS calculated for C30H33O3 [M+H]+: 441.2430, Found: 441.2412. 
61q was synthesized with 4 mol % IPrAuNTf2, 3 equiv. 
alkyne, 40 °C, 7h, in CHCl3. The title compound was 
isolated via flash chromatography on silica gel (Elution: 
hexanes/ethyl acetate = 19/1) as a colorless oil (82 mg, 
86%). 1H NMR (500 MHz; CDCl3): δ 7.63 (d, J = 7.4 Hz, 2H), 7.44 (d, J = 8.1 Hz, 2H), 7.37 (t, 
J = 7.6 Hz, 2H), 7.33 – 7.27 (m, 3H), 5.19 (d, J = 12.5 Hz, 1H), 5.09 (d, J = 12.5 Hz, 1H), 4.99 
(d, J = 8.8 Hz, 1H), 4.30 – 4.12 (m, 3H), 2.60 (ddd, J = 12.23, 7.46, 4.81 Hz, 1H), 2.36 – 2.00 
(m, 4H), 1.44 (s, 9H), 0.93 (d, J = 6.8 Hz, 3H), 0.84 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz; 
CDCl3): δ 172.21, 155.65, 143.54, 135.51, 131.91, 128.23, 128.09, 127.51, 125.27, 122.96, 
91.88, 84.47, 80.87, 79.81, 68.51, 66.36, 58.53, 42.96, 31.25, 28.30, 25.86, 19.00, 17.49. HRMS 
calculated for C29H36NO5 [M+H]+: 478.2594, Found: 478.2582. 
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61r was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 
40 °C, 4h, in CHCl3. The title compound was isolated via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 
19/1) as a colorless oil (59 mg, 69%). 1H NMR (500 MHz; 
CDCl3): δ 7.69 – 7.61 (m, 2H), 7.40 – 7.34 (m, 2H), 7.32 – 7.19 
(m, 4H), 4.27 – 4.13 (m, 2H), 2.87 (dd, J = 8.7, 3.9 Hz, 2H), 2.59 (ddd, J = 12.2, 7.6, 4.7 Hz, 
1H), 2.51 (dd, J = 19.0, 8.7 Hz, 1H), 2.44 – 2.38 (m, 1H), 2.34 – 2.23 (m, 2H), 2.23 – 1.92 (m, 
6H), 1.74 – 1.35 (m, 6H), 0.91 (s, 3H). 13C NMR (126 MHz; CDCl3): δ 220.71, 143.71, 140.19, 
136.45, 132.21, 129.03, 128.18, 127.43, 125.33, 125.23, 120.17, 90.57, 85.03, 80.95, 68.41, 
50.48, 47.93, 44.41, 43.05, 37.96, 35.82, 31.53, 29.05, 26.32, 25.86, 25.58, 21.56, 13.82. HRMS 
calculated for C30H33O2 [M+H]+: 425.2481, Found: 425.2480. 
61s was synthesized with 4 mol % IPrAuNTf2, 3 equiv. 
alkyne, 40 °C, 1.5h, in CHCl3. The title compound was 
isolated via flash chromatography on silica gel (Elution: 
hexanes/ethyl acetate = 15/1) as a white solid (69 mg, 
79%). 1H NMR (500 MHz; CDCl3): δ 7.69 – 7.61 (m, 3H), 7.47 (d, J = 8.2 Hz, 2H), 7.42 – 7.33 
(m, 7H), 7.30 – 7.27  (m, 1H), 7.16 – 7.13  (m, 1H),  5.34 (s, 2H), 4.30 – 4.12 (m, 2H), 4.07 (s, 
3H), 2.61 (ddd, J = 12.2, 7.5, 4.8 Hz, 1H), 2.34 – 2.21 (m, 1H), 2.21 – 2.13 (m, 1H), 2.13 – 2.01 
(m, 1H). 13C NMR (126 MHz; CDCl3): δ 178.32, 161.85, 143.57, 139.77, 136.20, 131.97, 
128.24, 127.79, 127.52, 125.82, 125.30, 125.15, 122.80, 122.62, 120.62, 110.61, 110.25, 91.78, 
84.59, 80.91, 68.51, 65.68, 43.00, 31.63, 25.87. HRMS calculated for C29H26NO3 [M+H]+: 
436.1913, Found: 436.1897. 
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61t was synthesized with 4 mol % IPrAuNTf2, 3 equiv. 
alkyne, 40 °C, 6h, in CHCl3. The title compound was 
isolated via flash chromatography on silica gel (Elution: 
hexanes/ethyl acetate = 15/1) as a colorless oil (80 mg, 
95%). 1H NMR (500 MHz; CDCl3): δ 7.68 (d, J = 7.8 Hz, 1H), 7.66 – 7.62 (m, 2H), 7.62 – 7.55 
(m, 2H), 7.52 – 7.35 (m, 7H), 7.35 – 7.27 (m, 2H), 5.40 (s, 2H), 4.32 – 4.10 (m, 2H), 2.61 (ddd, J 
= 12.2, 7.5, 4.8 Hz, 1H), 2.36 – 1.97 (m, 3H). 13C NMR (126 MHz; CDCl3): 159.30, 155.81, 
145.19, 143.53, 135.43, 132.00, 128.24, 128.17, 127.76, 127.52, 126.87, 125.28, 123.83, 123.12, 
122.85, 114.34, 112.39, 91.94, 84.49, 80.89, 68.51, 66.53, 42.98, 25.86. HRMS calculated for 
C28H23O4 [M+H]+: 423.1596, Found: 423.1586. 
61aa was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 20/1) as a yellow oil (37 mg, 
67%). 1H NMR (500 MHz; CDCl3): δ 7.57 (d, J = 8.8 Hz, 2H), 7.47 – 7.43 
(m, 2H), 7.33 – 7.26 (m, 3H), 6.90 (d, J = 8.8 Hz, 2H), 4.27 – 4.11 (m, 2H), 3.81 (s, 3H), 2.57 
(ddd, J = 11.9, 7.5, 4.5 Hz, 1H), 2.37 – 2.01 (m, 3H). 13C NMR (126 MHz; CDCl3): δ 158.99, 
135.65, 131.72, 128.19, 128.17, 126.62, 122.90, 113.53, 91.34, 84.93, 80.65, 68.27, 55.29, 42.82, 
25.85. HRMS calculated for C19H19O2 [M+H]+: 279.1385, Found: 279.1393. 
61ab was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 50/1) as a yellow oil (51 mg, 
83%). 1H NMR (500 MHz; CDCl3): δ 7.57 (d, J = 8.5 Hz, 2H), 7.47 – 7.44 
(m, 2H), 7.39 (d, J = 8.5 Hz, 2H), 7.31 – 7.28 (m, 3H), 4.26 – 4.13 (m, 2H), 2.59 (ddd, J = 12.2, 
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7.3, 4.6 Hz, 1H), 2.33 – 2.16 (m, 2H), 2.12 – 2.04 (m, 1H), 1.33 (s, 9H). 13C NMR (126 MHz; 
CDCl3): δ 150.35, 140.50, 131.73, 128.15, 126.10, 125.13, 125.04, 122.97, 91.47, 84.82, 80.77, 
77.25, 77.00, 76.74, 68.38, 42.74, 34.48, 31.35, 31.25, 25.90. HRMS calculated for C22H25O 
[M+H]+: 305.1905, Found: 305.1903. 
61ac was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
2.5h, in CHCl3. The title compound was isolated via flash chromatography 
on silica gel (Elution: hexanes/ethyl acetate = 20/1) as a yellow oil (47 mg, 
74%). 1H NMR (400 MHz; CDCl3): δ 7.74 (d, J = 8.2 Hz, 2H), 7.61 (d, J = 
8.3 Hz, 2H), 7.45 – 7.41 (m, 2H), 7.32 – 7.27 (m, 3H), 4.33 – 4.10 (m, 2H), 2.62 (ddd, J = 11.4, 
7.5, 4.3 Hz, 1H), 2.37 – 2.20 (m, 1H), 2.20 – 1.99 (m, 2H). 13C NMR (101 MHz; CDCl3): δ 
147.75, 131.72, 129.69 (q, JC-F = 32.26 Hz), 128.47, 128.22, 125.66, 125.48, 125.21 (q, JC-F = 
3.31 Hz), 122.44, 90.42, 85.41, 80.50, 68.65, 43.10, 25.81. HRMS calculated for C19H16F3O 
[M+H]+: 317.1153, Found: 317.1152 
61ad was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 50/1) as a pale-yellow oil (42 mg, 
78%). 1H NMR (400 MHz; CDCl3): δ 7.64 – 7.55 (m, 2H), 7.47 – 7.39 (m, 2H), 7.31 – 7.26 (m, 
3H), 7.03 (t, J = 8.7 Hz, 2H), 4.31 – 4.07 (m, 2H), 2.64 – 2.50 (m, 1H), 2.37 – 2.20 (m, 1H), 2.20 
– 2.00 (m, 2H). 13C NMR (101 MHz; CDCl3): δ 162.18 (d, JC-F = 245.67 Hz), 139.39, 131.70, 
128.33, 128.19, 127.09 (d, JC-F = 8.07 Hz), 122.66, 114.95 (d, JC-F = 21.47 Hz), 90.88, 85.18, 
80.50, 68.40, 43.07, 25.82. HRMS calculated for C18H16FO [M+H]+: 267.1185, Found: 
267.1145. 
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61ae was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
2.5h, in CHCl3. The title compound was isolated via flash chromatography 
on silica gel (Elution: hexanes/ethyl acetate = 20/1) as a pale-yellow oil (58 
mg, 88%). 1H NMR (400 MHz; CDCl3): δ 7.55 – 7.39 (m, 6H), 7.32 – 7.26 (m, 3H), 4.27 – 4.07 
(m, 2H), 2.57 (ddd, J = 11.2, 7.5, 4.0 Hz, 1H), 2.33 – 2.18 (m, 1H), 2.18 – 1.97 (m, 2H). 13C 
NMR (101 MHz; CDCl3): δ 142.82, 131.71, 131.27, 128.38, 128.20, 127.14, 122.57, 121.41, 
90.61, 85.23, 80.47, 68.50, 43.00, 25.80. HRMS calculated for C18H16BrO [M+H]+: 327.0385, 
Found: 327.0366. 
61af was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 50/1) as a pale-yellow oil (40 mg, 
76%). 1H NMR (500 MHz; CDCl3): δ 7.49 – 7.41 (m, 4H), 7.36 – 7.23 (m, 
4H), 7.11 (d, J = 7.6 Hz, 1H), 4.27 – 4.14 (m, 2H), 2.60 (ddd, J = 12.2, 7.6, 4.6 Hz, 1H), 2.39 (s, 
3H), 2.36 – 2.15 (m, 2H), 2.12 – 2.01 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 143.53, 137.85, 
131.75, 128.24, 128.20, 128.16, 128.13, 125.89, 122.93, 122.44, 91.38, 84.84, 80.88, 68.39, 
42.91, 25.84, 21.58. HRMS calculated for C19H19O [M+H]+: 263.1436, Found: 263.1433. 
61ag was synthesized with 4 mol% IPrAuNTf2, 3 equiv. alkyne, 60 °C, 3h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 20/1) as a yellow oil (51 mg, 
81%). 1H NMR (500 MHz; CDCl3): δ 7.91 (s, 1H), 7.84 (d, J = 7.8 Hz, 1H), 
7.56 (d, J = 7.8 Hz, 1H), 7.53 – 7.42 (m, 3H), 7.36 – 7.27 (m, 3H), 4.33 – 4.16 (m, 2H), 2.71 – 
2.58 (m, 1H), 2.40 – 2.24 (m, 1H), 2.21 – 1.99 (m, 2H). 13C NMR (126 MHz; CDCl3): δ 144.83, 
131.75, 130.72 (q, JC-F = 32.24 Hz), 128.88, 128.72, 128.49, 128.25, 124.38 (q, JC-F = 3.41 Hz), 
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124.16 (q, JC-F = 272.15 Hz), 122.47, 122.14 (q, JC-F = 3.58 Hz), 90.40, 85.50, 80.51, 68.63, 
43.16, 25.84. HRMS calculated for C19H16F3O [M+H]+: 317.1153, Found: 317.1151. 
61ah was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 50/1) as a pale-yellow oil (48 mg, 
84%). 1H NMR (400 MHz; CDCl3): δ 7.61 (s, 1H), 7.55 – 7.47 (m, 1H), 
7.46 – 7.41 (m, 2H), 7.32 – 7.22 (m, 5H), 4.29 – 4.08 (m, 2H), 2.58 (ddd, J = 11.7, 7.5, 4.5 Hz, 
1H), 2.35 – 2.19 (m, 1H), 2.19 – 1.96 (m, 2H). 13C NMR (101 MHz; CDCl3): δ 145.82, 134.14, 
131.73, 129.50, 128.39, 128.19, 127.62, 125.55, 123.58, 122.55, 90.54, 85.26, 80.39, 68.58, 
43.08, 25.80. HRMS calculated for C18H16ClO [M+H]+: 283.0890, Found: 283.0891. 
61ai was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated via flash chromatography on 
silica gel (Elution: hexanes/ethyl acetate = 50/1) as a colorless oil (49 mg, 
93%). 1H NMR (400 MHz; CDCl3): δ 7.67 (dd, J = 6.1, 2.9 Hz, 1H), 7.41 – 7.33 (m, 2H), 7.28 – 
7.22 (m, 3H), 7.18 (d, J = 2.9 Hz, 3H), 4.30 – 4.17 (m, 1H), 4.13 – 3.97 (m, 1H), 2.79 – 2.69 (m, 
1H), 2.61 (s, 3H), 2.30 – 2.15 (m, 2H), 2.07 – 1.94 (m, 1H). 13C NMR (101 MHz; CDCl3): δ 
141.45, 135.17, 131.70, 131.59, 128.11, 127.80, 127.40, 125.61, 124.51, 122.95, 91.09, 84.05, 
79.78, 67.49, 40.36, 25.70, 21.08. HRMS calculated for C19H19O [M+H]+: 263.1436, Found: 
263.1438. 
61aj was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, in 
CHCl3. The title compound was isolated via flash chromatography on silica gel 
(Elution: hexanes/ethyl acetate = 50/1) as a pale-yellow oil (48 mg, 81%). 1H 
NMR (400 MHz; CDCl3): δ 7.63 (d, J = 8.5 Hz, 1H), 7.86 (dd, J = 7.3, 3.2 Hz, 2H), 7.80 (d, J = 
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8.2 Hz, 1H), 7.58 – 7.42 (m, 3H), 7.40 – 7.32 (m, J = 6.6, 3.0 Hz, 2H), 7.26 – 7.19 (m, 3H), 4.37 
– 4.09 (m, 2H), 3.00 – 2.87 (m, 1H), 2.56 – 2.42 (m, 1H), 2.42 – 2.20 (m, 1H), 2.08 – 1.93 (m, 
1H). 13C NMR (101 MHz; CDCl3): δ 138.97, 134.50, 131.64, 130.09, 128.76, 128.59, 128.13, 
128.08, 126.10, 125.42, 125.29, 125.04, 122.88, 122.19, 91.95, 84.93, 79.66, 67.76, 41.31, 25.83. 
HRMS calculated for C22H19O [M+H]+: 299.1436, Found: 299.1433. 
61ak was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
1.5h, in CHCl3. The title compound was isolated via flash chromatography 
on silica gel (Elution: hexanes/ethyl acetate = 20/1) as a colorless oil (36 mg, 91%). 1H NMR 
(400 MHz; CDCl3): δ 7.42 – 7.38 (m, 2H), 7.30 – 7.24 (m, 3H), 4.08 – 3.86 (m, 2H), 2.28 – 2.08 
(m, 2H), 1.99 – 1.70 (m, 4H), 1.11 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz; CDCl3): δ 131.48, 
127.93, 127.79, 122.91, 91.17, 83.68, 80.41, 67.37, 38.17, 33.60, 25.30, 9.48. HRMS calculated 
for C14H17O [M+H]+: 201.1279, Found: 201.1274. 
61al was synthesized with 4 mol % IPrAuNTf2, 3 equiv. 
alkyne, 40 °C, 1.5h, in CHCl3. The title compound was 
isolated as a mixture of isomers via flash chromatography 
on silica gel (Elution: hexanes/ethyl acetate = 33/1) as a yellow oil (46 mg, 87%, 10:3 exo:endo 
mixture). 1H NMR (400 MHz; CDCl3): 7.50 – 7.08 (m, 10H), 4.37 – 4.06 (m, 0.26H, endo), 4.06 
– 3.80 (m, 1.74H), 3.18 – 3.03 (m, 1H), 2.24 – 1.78 (m, 5H). 13C NMR (126 MHz; CDCl3): δ 
149.63, 145.10, 143.48, 136.99, 135.86, 134.95, 131.58, 130.60, 129.45, 128.14, 128.06, 127.89, 
127.17, 126.60, 126.15, 122.99, 121.18, 119.11, 93.44, 91.49, 84.80, 79.92, 69.76, 67.84, 46.50, 
38.05, 33.88, 27.02, 25.51, 11.27. HRMS calculated for C19H19O [M+H]+: 263.14359, Found: 
263.1431. 
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61am was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 2.5h, 
in CHCl3. The title compound was isolated via flash chromatography on silica 
gel (Elution: hexanes/ethyl acetate = 25/1) as a colorless oil (31 mg, 84%). 1H NMR (500 MHz; 
CDCl3): δ 7.44 – 7.40 (m, 2H), 7.30 – 7.27 (m, 3H), 4.06 – 3.91 (m, 2H), 2.30 (ddd, J = 12.2, 
8.2, 4.4 Hz, 1H), 2.22 – 2.09 (m, 1H), 2.05 – 1.95 (m, 1H), 1.92 – 1.81 (m, 1H), 1.64 (s, 3H). 13C 
NMR (126 MHz; CDCl3): δ 131.66, 128.14, 128.04, 122.98, 92.33, 82.70, 76.39, 67.64, 40.16, 
27.70, 25.70. HRMS calculated for C13H15O [M+H]+: 187.1123, Found: 187.1117. 
61an was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, in 
CHCl3. The title compound was isolated via flash chromatography on silica gel 
(Elution: hexanes/ethyl acetate = 30/1) as a pale-yellow oil (37 mg, 93%). 1H NMR (500 MHz; 
CDCl3): δ 7.48 – 7.42 (m, 2H), 7.33 – 7.28 (m, 3H), 4.02 (td, J = 11.5, 3.6 Hz, 1H), 3.85 – 3.78 
(m, 1H), 1.96 – 1.83 (m, 2H), 1.76 – 1.69 (m, 1H), 1.61 – 1.53 (m, 6H). 13C NMR (126 MHz; 
CDCl3): δ 131.70, 128.22, 128.13, 122.97, 90.28, 85.66, 70.71, 64.20, 38.09, 30.05, 25.47, 20.76. 
HRMS calculated for C14H17O [M+H]+: 201.1279, Found: 201.1273. 
61ao was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, in 
CHCl3. The title compound was isolated via flash chromatography on silica gel 
(Elution: hexanes/ethyl acetate = 40/1) as a pale-yellow oil (34 mg, 79%). 1H 
NMR (500 MHz; CDCl3): δ 7.46 – 7.40 (m, 2H), 7.32 – 7.28 (m, 3H), 3.87 (ddd, J = 11.9, 8.6, 
3.1 Hz, 1H), 3.75 (dt, J = 12.7, 4.0 Hz, 1H), 2.09 (dd, J = 14.7, 9.4 Hz, 1H), 1.96 (dd, J = 14.7, 
8.2 Hz, 1H), 1.77 – 1.57 (m, 5H), 1.57 – 1.40 (m, 4H). 13C NMR (126 MHz; CDCl3): δ 131.70, 
128.17, 128.02, 123.09, 93.08, 83.07, 73.27, 64.88, 42.51, 30.86, 29.29, 28.47, 23.01. HRMS 
calculated for C15H19O [M+H]+: 215.1436, Found: 215.1425. 
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61ap was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 
4h, in CHCl3. The title compound was isolated as a mixture of isomers 
via flash chromatography on silica gel (Elution: hexanes/ethyl acetate = 
25/1) as a colorless oil (40 mg, 66%, 1:1 dr). 1H NMR (500 MHz; CDCl3): δ 7.69 – 7.60 (m, 
2H), 7.50 – 7.43 (m, 2H), 7.37 (td, J = 7.7, 3.1 Hz, 2H), 7.32 – 7.27 (m, 4H), 3.64 (td, J = 10.7, 
3.8 Hz, 0.5H), 3.51 – 3.39 (m, 0.5H), 2.77 (dd, J = 11.4, 5.2 Hz, 0.5H), 2.51 – 2.35 (m, 1H), 2.33 
– 2.22 (m, 1H), 2.13 – 1.85 (m, 3.5H), 1.76 (dd, J = 6.4, 3.1 Hz, 1H), 1.63 – 1.50 (m, 1H), 1.44 – 
1.08 (m, 3H). 13C NMR (126 MHz; CDCl3): δ 145.65, 145.30, 131.77, 131.73, 128.32, 128.15, 
128.11, 128.05, 127.25, 127.19, 125.48, 124.92, 123.04, 123.01, 93.33, 92.92, 85.17, 84.16, 
84.00, 79.81, 78.99, 49.91, 49.76, 46.31, 44.25, 31.83, 31.12, 28.65, 25.70, 25.54, 24.33, 24.26. 
HRMS calculated for C22H23O [M+H]+: 303.1749, Found: 303.1761. 
61aq was synthesized with 4 mol % IPrAuNTf2, 3 equiv. alkyne, 40 °C, 4h, 
in CHCl3. The title compound was isolated as a mixture of isomers via flash 
chromatography on silica gel (Elution: hexanes/ethyl acetate = 30/1) as a colorless oil (50 mg, 
95%, 3:2 dr). 1H NMR (400 MHz; CDCl3): δ 7.71 – 7.59 (m, 2H), 7.49 – 7.18 (m, 8H), 4.59 – 
4.47 (m, 0.6H), 4.46 – 4.34 (m, 0.4H), 2.70 – 2.53 (m, 1H), 2.40 – 2.14 (m, 2H), 2.08 – 1.95 (m, 
0.4H), 1.72 – 1.56 (m, 0.6H), 1.46 (d, J = 6.1 Hz, 1.2H), 1.40 (d, J = 6.1 Hz, 1.8H). 13C NMR 
(101 MHz; CDCl3): δ 144.22, 143.96, 131.72, 131.62, 128.14, 127.39, 127.34, 125.37, 125.19, 
123.05, 122.93, 92.56, 91.78, 84.80, 84.63, 81.04, 80.74, 75.70, 44.02, 43.27, 34.28, 32.89, 
22.39, 21.04. HRMS calculated for C19H19O [M+H]+: 263.1436, Found: 263.1430. 
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3.3.5 General Procedure for Synthesizing Dihydrooxepine Diels Alder Adducts 
              
To a 2 mL vial charged with IPrAuNTf2 (17.33 mg, 0.02 mmol) was sequentially added 
CHCl3 (1.6 mL), 47 (1.0 eq, 0.4 mmol), and 62 (1.1 eq, 0.44 mmol). The reaction mixture was 
purged with argon for at least 1 minute and then stirred at 40 °C. After the reaction is complete 
(6h-16h), the mixture was passed through a short silica pad and collected in a new 5mL-vial. The 
silica pad was rinsed with 2.0 mL CHCl3. The dienophile was then added (0.6 mmol), the vial 
sealed securely with parafilm, and the resulting mixture was stirred for 13h at 75 °C. The 
reaction was concentrated in vacuo and purified via flash column chromatography on silica gel 
with 3:1 hexanes/ethyl acetate as eluent to afford the desired product.  
64b was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate = 
3/1) as a yellow oil (107 mg, 71% yield) and crystallized by slow evaporation of 
a CHCl3/DCM/Hexanes solution at room temperature. 1H NMR (400 MHz; 
CDCl3): δ 7.83 – 7.76 (m, 2H), 7.61 – 7.45 (m, 8H), 6.75 (s, 1H), 4.19 – 4.10 
(m, 2H), 3.80 (td, J = 12.3, 4.0 Hz, 1H), 2.93 – 2.81 (m, 1H), 2.08 – 1.97 (m, 1H). 13C NMR 
(126 MHz; CDCl3): δ 144.83, 136.45, 135.11, 130.78, 130.36, 129.61, 128.72, 127.18, 125.89, 
122.74, 112.92, 111.35, 111.22, 110.28, 81.89, 62.09, 47.12, 45.49, 29.70, 29.09. HRMS 
calculated for C24H17N4O [M+H]
+: 377.1402, Found: 377.1394. 
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64c was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate 
= 3/1) as a yellow oil (114 mg, 73% yield). 1H NMR (400 MHz; CDCl3): δ 
7.79 – 7.71 (m, 2H), 7.56 – 7.47 (m, 3H), 7.39 – 7.19 (m, 4H), 6.56 (s, 1H), 
4.24 (dd, J = 12.8, 6.8 Hz, 1H), 3.95 (td, J = 12.2, 4.3 Hz, 1H), 3.88  – 3.82 
(m, 1H), 3.01 – 2.86 (m, 1H), 2.55 (s, 3H), 2.21  –  2.01 (m, 1H). 13C NMR (126 MHz; CDCl3): 
δ 144.81, 136.32, 136.03, 135.40, 131.73, 130.36, 129.78, 128.77, 127.80, 127.07, 126.85, 
126.72, 113.04, 111.55, 111.25, 110.22, 81.97, 62.50, 56.15, 48.52, 45.11, 29.60, 20.89. HRMS 
calculated for C25H19N4O [M+H]
+: 391.1559, Found: 391.1563. 
64d was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl 
acetate = 3/1) as a yellow oil (95 mg, 61% yield).  1H NMR (500 MHz; 
CDCl3): δ 7.83 – 7.71 (m, 2H), 7.57 – 7.45 (m, 3H), 7.45 – 7.27 (m, 4H), 
6.72 (s, 1H), 4.18 – 4.07 (m, 2H), 3.79 (td, J = 12.3, 4.0 Hz, 1H), 2.95 – 2.80 
(m, 1H), 2.42 (s, 3H), 2.08 – 1.99 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 144.89, 139.48, 
136.47, 135.09, 131.54, 130.32, 129.46, 128.70, 127.17, 126.46, 122.96, 122.43, 112.87, 111.31, 
111.20, 110.23, 81.86, 62.03, 47.13, 45.45, 35.85, 29.10, 21.47. HRMS calculated for 
C25H19N4O [M+H]
+: 391.1559, Found: 391.1547. 
64e was synthesized using general procedure B. The title compound was isolated 
via flash chromatography on silica gel (Elution: hexanes/ethyl acetate = 3/1) as a 
yellow oil (112 mg, 65% yield). 1H NMR (400 MHz; CDCl3): δ 7.89 – 7.68 (m, 
2H), 7.68 – 7.44 (m, 7H), 6.72 (s, 1H), 4.28 – 4.01 (m, 2H), 3.90 – 3.64 (m, 1H), 
2.99 – 2.73 (m, 1H), 2.15 – 1.89 (m, 1H), 1.45 – 1.27 (m, 9H). 13C NMR (101 
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MHz; CDCl3): 154.43, 144.53, 136.54, 132.06, 130.28, 128.67, 127.16, 126.54, 125.58, 121.66, 
112.89, 111.33, 111.24, 110.27, 81.91, 62.04, 61.99, 46.95, 45.46, 34.96, 34.92, 31.39, 31.10, 
29.06. HRMS calculated for C28H25N4O [M+H]
+: 433.2028, Found: 433.2012. 
64f was synthesized using general procedure B. The title compound was isolated 
via flash chromatography on silica gel (Elution: hexanes/ethyl acetate = 3/1) as a 
yellow solid (122 mg, 67% yield). 1H NMR (500 MHz; CDCl3): δ 7.81 – 7.77 
(m, 2H), 7.65 (d, J = 8.3 Hz, 2H), 7.56 – 7.51 (m, 3H), 7.43 (d, J = 8.3 Hz, 2H), 
6.78 (s, 1H), 4.22 – 4.08 (m, 2H), 3.78 (td, J = 12.3, 3.8 Hz, 1H), 2.95 – 2.78 (m, 
1H), 2.08 – 1.99 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 143.83, 136.24, 133.94, 132.85, 
130.45, 128.77, 127.40, 127.13, 125.32, 123.32, 112.87, 111.28, 111.07, 110.15, 81.85, 77.32, 
77.07, 76.82, 62.09, 56.23, 46.98, 45.47, 29.03. HRMS calculated for C24H16BrN4O [M+H]
+: 
455.0508, Found: 455.0490. 
64g was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate 
= 3/1) as a colorless oil (105 mg, 59% yield) and crystallized by slow 
evaporation of a CDCl3 solution at room temperature. 1H NMR (500 MHz; 
CDCl3): δ 7.82 – 7.73 (m, 4H), 7.66 (d, J = 8.2 Hz, 2H), 7.55 – 7.49 (m, 3H), 
6.84 (s, 1H), 4.24 – 4.08 (m, 2H), 3.79 (td, J = 12.3, 4.0 Hz, 1H), 3.01 – 2.84 
(m, 1H), 2.12 – 1.98 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 138.50, 136.01, 132.63 (q, JC-F = 
33.08 Hz), 130.54, 128.82, 127.89, 127.09, 126.66 (q, JC-F = 3.22 Hz), 126.40, 125.17, 123.49 (q, 
JC-F = 272.64 Hz), 112.83, 111.17, 110.92, 109.99, 81.77, 62.11, 56.23, 47.22, 45.46, 29.01. 
HRMS calculated for C25H16F3N4O [M+H]
+: 445.1276, Found: 445.1246. 
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64h was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate = 
3/1) as a yellow solid (95 mg, 61% yield). 1H NMR (400 MHz; CDCl3): 7.64 – 
7.27 (m, 9H), 6.74 (s, 1H), 4.18 – 4.08 (m, 2H), 3.79 (td, J = 12.2, 4.1 Hz, 1H), 
2.96 – 2.78 (m, 1H), 2.43 (s, 3H), 2.10 – 1.97 (m, 1H). 13C NMR (126 MHz; 
CDCl3): δ 144.68, 138.60, 136.38, 135.16, 131.08, 130.73, 129.59, 128.58, 127.70, 125.88, 
124.24, 122.91, 112.92, 111.33, 111.23, 110.29, 81.86, 62.02, 56.33, 47.15, 45.53, 29.05, 21.68. 
HRMS calculated for C25H19N4O [M+H]
+: 391.1559, Found: 391.2515. 
64i was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate 
= 3/1) as a pale-yellow foam (107 mg, 68% yield). 1H NMR (500 MHz; 
CDCl3): δ 7.65 – 7.50 (m, 7H), 7.25 – 7.20 (m, 2H), 6.70 (d, J = 1.1 Hz, 1H), 
4.30 – 4.09 (m, 2H), 3.82 (td, J = 12.3, 4.1 Hz, 1H), 3.01 – 2.60 (m, 1H), 2.16 
– 1.99 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 162.65 (d, JC-F = 248.16 Hz), 145.22, 138.95 (d, 
JC-F = 7.09 Hz), 134.89, 130.93, 130.39 (d, JC-F = 8.02 Hz), 129.65, 127.51(d, JC-F = 199.51 Hz), 
125.88, 122.88 (d, JC-F = 2.20 Hz), 122.13, 117.48 (d, JC-F = 21.04 Hz), 114.84 (d, JC-F = 24.33 
Hz), 112.76, 111.11 (d, JC-F = 17.34 Hz), 110.01, 81.47, 62.23, 56.07, 47.14, 45.40, 29.03. 
HRMS calculated for C24H16FN4O [M+H]
+: 395.1308, Found: 395.1290. 
64j was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate 
= 3/1) as a yellow oil (97 mg, 59% yield). 1H NMR (500 MHz; CDCl3): δ 7.81 
(t, J = 1.7 Hz, 1H), 7.69 – 7.64 (m, 1H), 7.59 – 7.44 (m, 7H), 6.68 (s, 1H), 4.22 
– 4.13 (m, 2H), 3.81 (td, J = 12.2, 4.1 Hz, 1H), 2.96 – 2.84 (m, 1H), 2.10 – 
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2.03 (m, 1H). 13C NMR (126 MHz; CDCl3): δ 145.30, 138.40, 135.04, 134.88, 130.94, 130.61, 
129.96, 129.64, 127.53, 125.87, 125.35, 122.01, 112.72, 111.13, 111.00, 109.93, 81.43, 62.21, 
47.18, 45.38, 29.69, 29.01. HRMS calculated for C24H16ClN4O [M+H]
+: 411.1013, Found: 
411.0985. 
64k was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate = 
5/1) as a white solid (111 mg, 64% yield). 1H NMR (500 MHz; CDCl3): δ 7.80 
– 7.69 (m, 2H), 7.61 – 7.48 (m, 7H), 6.78 (d, J = 1.1 Hz, 1H), 4.20 – 4.11 (m, 
2H), 3.80 (td, J = 12.3, 4.0 Hz, 1H), 2.95 – 2.85 (m, 1H), 2.09 – 1.98 (m, 1H), 
1.38 (s, 9H). 13C NMR (126 MHz; CDCl3): δ 153.54, 144.55, 135.16, 133.47, 
130.74, 129.60, 126.96, 125.89, 125.69, 123.07, 113.03, 111.44, 111.28, 110.41, 81.90, 62.03, 
56.34, 47.17, 45.53, 34.80, 31.22, 29.16. HRMS calculated for C28H25N4O [M+H]
+: 433.2028, 
Found: 433.2014. 
64l was synthesized using general procedure B. The title compound was isolated 
via flash chromatography on silica gel (Elution: hexanes/ethyl acetate = 3/1) as a 
yellow solid (98 mg, 54% yield). 1H NMR (500 MHz; CDCl3): 7.65 (d, J = 9.2 
Hz, 4H), 7.59 – 7.48 (m, 5H), 6.68 (s, 1H), 4.24 – 4.11 (m, 2H), 3.81 (td, J = 
12.1, 4.0 Hz, 1H), 2.95 – 2.83 (m, 1H), 2.09 – 2.00 (m, 1H). 13C NMR (126 
MHz; CDCl3): δ 145.26, 135.43, 134.92, 131.94, 130.92, 129.64, 128.87, 
125.86, 125.19, 122.04, 112.74, 111.22, 111.01, 110.03, 81.69, 62.16, 47.17, 45.31, 29.69, 29.01. 
HRMS calculated for C24H16BrN4O [M+H]
+: 455.0508, Found: 455.0471. 
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64m was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl acetate 
= 3/1) as a yellow solid (124 mg, 81% yield). 1H NMR (500 MHz; CDCl3): δ 
7.71 (d, J = 2.0 Hz, 1H), 7.61 – 7.35 (m, 7H), 6.69 (s, 1H), 4.16 – 4.02 (m, 2H), 
3.81 (td, J = 12.2, 4.0 Hz, 1H), 2.93 – 2.76 (m, 1H), 2.07 – 1.90 (m, 1H). 13C NMR (126 MHz; 
CDCl3): δ 144.67, 138.45, 134.92, 130.84, 129.61, 127.13, 126.23, 125.91, 122.89, 112.90, 
111.39, 111.13, 110.35, 81.30, 62.12, 55.87, 47.12, 45.34, 29.14. HRMS calculated for 
C22H15N4OS [M+H]
+: 383.0967, Found: 383.0951. 
64n was synthesized using general procedure B. The title compound was 
isolated via flash chromatography on silica gel (Elution: hexanes/ethyl 
acetate = 3/1) as a pale-yellow oil (116 mg, 74% yield). 1H NMR (500 
MHz; CDCl3): δ 7.90 – 7.77 (m, 2H), 7.63 – 7.43 (m, 8H), 6.78 (s, 1H), 4.11 (d, J = 6.4 Hz, 1H), 
4.06 – 3.97 (m, 1H), 2.55 (dd, J = 15.4, 10.7 Hz, 1H), 2.27 – 2.10 (m, 1H), 1.43 (d, J = 6.2 Hz, 
3H). 13C NMR (126 MHz; CDCl3): δ 145.03, 136.70, 135.11, 130.70, 130.30, 129.58, 128.75, 
127.14, 125.85, 123.55, 112.95, 111.39, 111.21, 110.26, 81.39, 77.30, 77.04, 76.79, 69.75, 56.34, 
46.76, 45.32, 36.37, 20.27. HRMS calculated for C25H19N4O [M+H]
+: 391.1559, Found: 
391.1542. 
 
3.3.6 1H-NMR Monitoring of Ring Expansion 
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To a 2 mL vial charged with IPrAuNTf2 (17.33 mg, 0.02 mmol) was sequentially added 
CHCl3 (1.6 mL), 47a (1.0 eq, 0.4 mmol), and 62b (1.1 eq, 0.44 mmol). The reaction mixture was 
purged with argon for at least 1 minute and then stirred at 40 °C. The yield of the products was 
determined via 1H-NMR with 1,3,5-trimethoxybenzene as the internal standard.  
 
 
Figure 3.6. 1H-NMR monitoring of ring expansion. 
 
3.3.7 X-Ray Crystallographic Data for 61m, 64b, and 64g        
The X-ray diffraction data for all compounds were measured on Bruker D8 Venture 
PHOTON 100 CMOS system equipped with a Cu Kα INCOATEC ImuS micro-focus source (λ = 
1.54178 Å). Indexing was performed using APEX3 [1] (Difference Vectors method). Data 
integration and reduction were performed using SaintPlus 6.01 [2]. Absorption correction was 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• = 61b 
• = 60b 
t = 10h 
t = 0.5h 
t = 1.5h 
t = 6.4h 
t = 8.6h 
t = 9.6h 
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performed by a multi-scan method implemented in SADABS [3]. Space groups were determined 
using XPREP implemented in APEX3 [1]. Structures were solved using SHELXS-97 (direct 
methods) and refined using SHELXL-2014 [4-6] (full-matrix least-squares on F2) through 
OLEX2 interface program [7]. All non-hydrogen atoms were refined anisotropically. Hydrogen 
atoms of -CH and -CH2 groups were placed in geometrically calculated positions and were 
included in the refinement process using riding model with isotropic thermal parameters: 
Uiso(H) = 1.2Ueq(-CH,-CH2). Compound 64b: Crystal was a twin. The data have been 
integrated using two orientation matrices (twin law: -1 0 0 0 -1 0 0.4 0 1) and HKLF5 reflection 
file was used for refinement. Compound 64g: The disordered –CF3 group has been refined using 
distance (DFIX), angular (DANG) restraints and ADP restraints (RIGU). EADP constraint has 
been used for closely overlapping atoms C70A and C70B. Crystal data and refinement 
conditions are shown in Tables 1-3. 
 
[1] Bruker (2016). APEX3 (Version 2015.9). Bruker AXS Inc., Madison, Wisconsin, USA. 
[2] Bruker (2016) SAINT V8.35A. Data Reduction Software. 
[3] Sheldrick, G. M. (1996). SADABS. Program for Empirical Absorption 
Correction. University of Gottingen, Germany. 
[4] Sheldrick, G.M. (1997) SHELXL-97. Program for the Refinement of Crystal 
[5] Sheldrick, G.M. (1990) Acta Cryst. A46, 467-473 
[6] Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122. 
[7] Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H., OLEX2: A 
complete structure solution, refinement and analysis program (2009). J. Appl. Cryst., 42, 339-
341 
81 
 
 
 
Figure 3.7. Perspective view of molecular structure C22H20FeO with atom labeling.  
 
Table 3.6. Crystal data and structure refinement for 61m. 
Identification code 61m 
Empirical formula C22H20FeO 
Formula weight 356.23 
Temperature/K 100.0 
Crystal system triclinic 
Space group P-1 
a/Å 7.2823(2) 
Identification code 61m 
Empirical formula C22H20FeO 
Formula weight 356.23 
Temperature/K 100.0 
Crystal system triclinic 
Space group P-1 
a/Å 7.2823(2) 
b/Å 10.5512(3) 
c/Å 11.3059(3) 
α/° 92.6290(10) 
β/° 100.8210(10) 
γ/° 101.1970(10) 
Volume/Å3 833.96(4) 
Z 2 
ρcalcg/cm3 1.419 
μ/mm-1 7.265 
F(000) 372.0 
Crystal size/mm3 0.2 × 0.2 × 0.05 
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Table 3.6. (Continued) Crystal data and structure refinement for 61m. 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 7.99 to 133.044 
Index ranges -8 ≤ h ≤ 8, -12 ≤ k ≤ 12, -12 ≤ l ≤ 13 
Reflections collected 9825 
Independent reflections 2911 [Rint = 0.0480, Rsigma = 0.0440] 
Data/restraints/parameters 2911/0/217 
Goodness-of-fit on F2 1.033 
Final R indexes [I>=2σ (I)] R1 = 0.0329, wR2 = 0.0734 
Final R indexes [all data] R1 = 0.0373, wR2 = 0.0761 
Largest diff. peak/hole / e Å-3 0.30/-0.32 
 
 
Figure 3.8. Perspective view of molecular structure C24H16N4O with atom labeling.  
 
Table 3.7. Crystal data and structure refinement for 64b. 
Identification code 64b 
Empirical formula C24H16N4O 
Formula weight 376.41 
Temperature/K 100.03 
Crystal system monoclinic 
Space group P21/c 
a/Å 14.4429(4) 
b/Å 8.4127(2) 
c/Å 15.5871(4) 
α/° 90 
β/° 100.5300(10) 
γ/° 90 
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Table 3.7. (Continued) Crystal data and structure refinement for 64b. 
 
Volume/Å3 1862.00(8) 
Z 4 
ρcalcg/cm3 1.343 
μ/mm-1 0.680 
F(000) 784.0 
Crystal size/mm3 0.276 × 0.192 × 0.088 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 6.224 to 136.462 
Index ranges -17 ≤ h ≤ 17, 0 ≤ k ≤ 10, 0 ≤ l ≤ 18 
Reflections collected 3385 
Independent reflections 3385 [Rint = ?, Rsigma = 0.0493] 
Data/restraints/parameters 3385/0/263 
Goodness-of-fit on F2 1.165 
Final R indexes [I>=2σ (I)] R1 = 0.0649, wR2 = 0.1210 
Final R indexes [all data] R1 = 0.0819, wR2 = 0.1291 
Largest diff. peak/hole / e Å-3 0.26/-0.26 
 
 
Figure 3.9. Perspective view of molecular structure C25H15F3N4O with atom labeling.   
 
Table 3.8. Crystal data and structure refinement for 64g. 
Identification code 64g 
Empirical formula C25H15F3N4O 
Formula weight 444.41 
Temperature/K 100.04 
Crystal system triclinic 
Space group P-1 
a/Å 10.3921(3) 
b/Å 11.9914(3) 
c/Å 17.5331(4) 
α/° 80.3565(12) 
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Table 3.8. (Continued) Crystal data and structure refinement for 64g. 
β/° 89.9964(14) 
γ/° 76.6551(13) 
Volume/Å3 2094.17(9) 
Z 4 
ρcalcg/cm3 1.410 
μ/mm-1 0.907 
F(000) 912.0 
Crystal size/mm3 0.31 × 0.23 × 0.19 
Radiation CuKα (λ = 1.54178) 
2Θ range for data collection/° 5.116 to 154.388 
Index ranges -12 ≤ h ≤ 13, -15 ≤ k ≤ 15, -21 ≤ l ≤ 22 
Reflections collected 30098 
Independent reflections 8427 [Rint = 0.0517, Rsigma = 0.0460] 
Data/restraints/parameters 8427/34/612 
Goodness-of-fit on F2 1.047 
Final R indexes [I>=2σ (I)] R1 = 0.0463, wR2 = 0.0938 
Final R indexes [all data] R1 = 0.0719, wR2 = 0.1060 
Largest diff. peak/hole / e Å-3 0.31/-0.24 
 
 
3.4 Conclusion 
In summary, we have developed a gold-catalyzed tandem alkynylation of vinyl ethers 
generated in-situ via alkynols. These alkynylated ethers undergo an additional gold-catalyzed 
ring expansion to form 2,3-dihydrooxepines. 
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T.; Carreira, E. M. J. Am. Chem. Soc. 2005, 127, 9682. (c) Han, J.; Xu, B.; Hammond, G. B. J. 
Am. Chem. Soc. 2010, 132, 916. 
8. (a) Yan, J.; Tay, G. L.; Neo, C.; Lee, B. R.; Chan, P. W. H. Org. Lett. 2015, 17, 4176; (b) 
Borrero, N. V.; DeRatt, L. G.; Barbosa, L. F.; Abboud, K. A.; Aponick, A. Org. Lett. 2015, 17, 
1754; (c) Gonzalez, A. Z.; Toste, D. F. Org. Lett. 2010, 12, 200. 
9. Nguyen, T. X. M.; Son-Meniel, B.; Jullian, J.-C.; Figadere. B. Lett. Org. Chem. 6, 630. 
86 
 
10. For recent examples of gold-catalyzed ring expansions, see: (a) Zhu, L.-L.; Li, X.-X.; 
Zhou, W.; Li, X.; Chen, Z. J. Org. Chem. 2011, 76, 8814; (b) Bolte, B.; Gagosz, F. J. Am. Chem. 
Soc. 2011, 133, 7696; (c) Kim, K.-D.; Yeom, H.-S.; Shin, S; Shin, S. Tetrahedron 2012, 68, 
5241; (d) Yuan, W.; Dong, X.; Wei, Y.; Shi, M. Chem. Eur. J. 2012, 18, 10501; (e) An, J.-H.; Yun, 
H.; Shin, S.; Shin, S. Adv. Synth. Catal. 2014, 356, 3749; (f) Zhao, J.; Liu, J.; Xie, X.; Li, S.; Liu, 
Y. Org. Lett. 2015, 17, 5926; (g) Zhao, J. D.; Liu, J.; Xie, X.; Li, S.; Liu, Y.  Zhao, J. Liu, X. Org. 
Lett. 2015, 17, 5926; (h) Chen, M.; Sun, N.; Xu, W.; Zhao, J. Wang, G.; Liu, Y. Chem. Eur. J. 
2015, 21, 18571.  
11. Díez-González, S.; Marion N.; Nolan, S. P. Chem. Rev. 2009, 109, 3612. 
  
87 
 
 
 
 
APPENDIX A: SPECTRAL DATA FOR CHAPTER 2 
       
 
 
 
88 
 
 
  
  
89 
 
 
 
  
90 
 
 
 
 
  
91 
 
 
 
 
 
92 
 
 
 
 
 
93 
 
 
 
  
94 
 
 
 
  
95 
 
 
 
  
96 
 
 
 
  
97 
 
 
 
  
98 
 
 
 
 
99 
 
 
 
100 
 
 
 
  
101 
 
 
 
  
102 
 
 
 
103 
 
 
 
104 
 
 
 
  
105 
 
 
 
106 
 
 
 
  
107 
 
 
 
108 
 
 
 
  
109 
 
 
 
  
110 
 
 
 
  
111 
 
 
 
  
112 
 
 
 
  
113 
 
 
 
114 
 
 
 
  
115 
 
 
 
116 
 
 
  
 
117 
 
 
 
C 
C 
118 
 
 
  
C 
119 
 
 
 
 
APPENDIX B: SPECTRAL DATA FOR CHAPTER 3 
 
 
 
120 
 
 
 
121 
 
 
 
122 
 
 
 
123 
 
 
 
124 
 
 
 
125 
 
 
 
 
 
126 
 
 
 
 
 
127 
 
 
 
 
128 
 
 
 
 
 
129 
 
 
 
 
 
130 
 
 
 
 
 
131 
 
 
 
 
 
132 
 
   
 
 
 
133 
 
 
 
 
 
134 
 
 
 
 
 
135 
 
 
 
 
 
136 
 
 
 
 
 
137 
 
 
 
 
 
138 
 
 
 
 
 
139 
 
 
 
 
 
140 
 
 
 
 
 
141 
 
 
 
 
 
142 
 
 
 
 
 
143 
 
 
 
 
 
144 
 
 
 
 
 
145 
 
 
 
 
 
146 
 
 
 
 
 
147 
 
 
 
 
 
148 
 
 
 
 
 
149 
 
 
 
 
 
150 
 
 
 
 
 
151 
 
 
 
 
 
152 
 
 
 
 
 
153 
 
 
 
 
 
154 
 
  
 
 
 
155 
 
 
 
 
 
156 
 
 
 
 
 
157 
 
  
 
 
158 
 
  
 
 
 
159 
 
 
 
 
  
160 
 
 
 
 
 
161 
 
 
 
 
 
162 
 
 
 
 
 
163 
 
 
 
 
 
164 
 
 
 
 
 
165 
 
 
 
 
 
166 
 
 
 
 
 
167 
 
 
 
 
 
168 
 
 
 
 
 
169 
 
 
 
 
 
170 
 
 
 
 
 
171 
 
 
 
 
 
172 
 
 
 
 
 
 
